{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:19:39Z","timestamp":1782731979587,"version":"3.54.5"},"reference-count":326,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychiatr"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alleviating the multiple problems of children with autism spectrum disorder (ASD) and its comorbid conditions presents major challenges for the affected children, parents, and therapists. Because of a\u00a0complex psychopathology, structured therapy and parent training are not always sufficient, especially for those patients with intellectual disability (ID) and multiple comorbidities. Moreover, structured therapy is not available for a\u00a0large number of patients, and pharmacological support is often needed, especially in those children with additional attention deficit\/hyperactivity and oppositional defiant, conduct, and sleep disorders.<\/jats:p>","DOI":"10.1007\/s40211-021-00395-9","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T13:06:07Z","timestamp":1624453567000},"page":"113-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Practitioner\u2019s review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions","Practitioner Review: Medikament\u00f6se Behandlung von Kindern und Jugendlichen mit Autismus-Spektrum-St\u00f6rung (ASS) und Komorbidit\u00e4ten"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0496-1453","authenticated-orcid":false,"given":"Christian","family":"Popow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Ohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Plener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"issue":"5","key":"395_CR1","doi-asserted-by":"publisher","first-page":"e1269","DOI":"10.7759\/cureus.1269","volume":"9","author":"M Aadil","year":"2017","unstructured":"Aadil\u00a0M, Cosme\u00a0RM, Chernaik\u00a0J. Mindfulness-based cognitive behavioral therapy as an adjunct treatment of Attention Deficit Hyperactivity disorder in young adults: A\u00a0literature review. Cureus. 2017;9(5):e1269. https:\/\/doi.org\/10.7759\/cureus.1269.","journal-title":"Cureus"},{"issue":"328","key":"395_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-019-2259-4","volume":"19","author":"R Agarwal","year":"2019","unstructured":"Agarwal\u00a0R, Burke\u00a0SL, Maddux\u00a0M. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders. BMC Psychiatry. 2019;19(328):1\u201310. https:\/\/doi.org\/10.1186\/s12888-019-2259-4.","journal-title":"BMC Psychiatry"},{"key":"395_CR3","first-page":"311","volume-title":"16th World Congress of IACAPAP","author":"A Allen","year":"2004","unstructured":"Allen\u00a0A, Kurlan\u00a0R, Gilbert\u00a0D, Dunn\u00a0D, Dallee\u00a0FR, Spencer\u00a0T. Atomoxetine treatment in children with ADHD and comorbid tic disorders. In: 16th World Congress of IACAPAP. Darmstadt: Steinkopff; 2004. pp.\u00a0311\u201331."},{"issue":"1","key":"395_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/104454603321666171","volume":"13","author":"MG Aman","year":"2003","unstructured":"Aman MG, Buican B, Arnold LE. Methylphenidate treatmentin children with borderline IQ and mental retardation: analysis of three aggregated studies. J\u00a0Child Adolesc Psychopharmacol. 2003;13(1):29\u201340.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"395_CR5","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.ridd.2014.03.006","volume":"35","author":"MG Aman","year":"2014","unstructured":"Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, et al. A\u00a0review of atomoxetine effects in young people with developmental disabilities. Res Dev Disabil. 2014;35(6):1412\u201324. https:\/\/doi.org\/10.1016\/j.ridd.2014.03.006.","journal-title":"Res Dev Disabil"},{"key":"395_CR6","doi-asserted-by":"crossref","unstructured":"American Academy of Child and Adolescent Psychiatry Committee on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with obsessive\u2013compulsive disorder. J\u00a0Am Acad Child Adoles Psych. 2012;51(1):98\u2013113.","DOI":"10.1016\/j.jaac.2011.09.019"},{"key":"395_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.brainres.2014.01.049","volume":"2014","author":"E Anagnostou","year":"1580","unstructured":"Anagnostou E, Soorya L, Brian J, Dupuis A, Mankad D, Smile S, et al. Intranasal oxytocin in the treatment of autism spectrum disorder: a\u00a0review of literature and early safety and efficacy data in youth. Brain Res Brain Res Protoc. 1580;2014:188\u201398. https:\/\/doi.org\/10.1016\/j.brainres.2014.01.049.","journal-title":"Brain Res Brain Res Protoc"},{"key":"395_CR8","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0910249107","volume":"107","author":"E Andari","year":"2010","unstructured":"Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci Usa. 2010;107:4389\u201394.","journal-title":"Proc Natl Acad Sci Usa"},{"key":"395_CR9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1176\/ajp.141.10.1195","volume":"141","author":"LT Anderson","year":"1984","unstructured":"Anderson LT, Campbell M, Grega DM, Perry R, Small AM, Green WH. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry. 1984;141:1195\u2013202.","journal-title":"Am J Psychiatry"},{"issue":"10","key":"395_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1586\/14737175.2013.840417","volume":"13","author":"KM Antshel","year":"2013","unstructured":"Antshel KM, Zhang-James Y, Faraone SV. The comorbidity of ADHD and autism spectrum disorder. Expert Rev Neurother. 2013;13(10):1117\u201328.","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"395_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/jcpp.12097","volume":"54","author":"LE Arnold","year":"2013","unstructured":"Arnold LE. Commentary: filling out the evidence base for treatment of attention-deficit hyperactivity disorder symptoms in children with intellectual and developmental disability: conclusions for clinicians\u00a0\u2013 response to Simonoff et al. J\u00a0Child Psychol Psychiatry Allied Discip. 2013;54(6):701\u20134.","journal-title":"J Child Psychol Psychiatry Allied Discip"},{"issue":"1","key":"395_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","volume":"25","author":"P Ashwood","year":"2011","unstructured":"Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2011;25(1):40\u20135. https:\/\/doi.org\/10.1016\/j.bbi.2010.08.003.","journal-title":"Brain Behav Immun"},{"key":"395_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/BF01837709","volume":"117","author":"H Asperger","year":"1944","unstructured":"Asperger H. Die \u201eAutistischen Psychopathen\u201d im Kindesalter [The \u201cAutistic Psychopaths\u201d in Childhood]. Arch Psychiatr. 1944;117:76\u2013136. https:\/\/doi.org\/10.1007\/BF01837709.","journal-title":"Arch Psychiatr"},{"issue":"9","key":"395_CR14","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.ridd.2013.05.028","volume":"34","author":"CJ Bachmann","year":"2013","unstructured":"Bachmann CJ, Manthey T, Kamp-Becker I, Glaeske G, Hoffmann F. Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany. Res Dev Disabil. 2013;34(9):2551\u201363.","journal-title":"Res Dev Disabil"},{"issue":"10","key":"395_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamapsychiatry.2019.1411","volume":"76","author":"D Bai","year":"2019","unstructured":"Bai D, Hon Kei Yip B, Windham GC, Sourander A, Francis R, Yoffe R, et al. Association of genetic and environmental factors with autism in a\u00a05-country cohort. Jama Psychiatry. 2019;76(10):1035\u201343. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.1411.","journal-title":"Jama Psychiatry"},{"issue":"2","key":"395_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/21622965.2012.703890","volume":"1","author":"T Bailey","year":"2012","unstructured":"Bailey T. Beyond DSM: The role of auditory processing in attention and its disorders. Appl Neuropsychol Child. 2012;1(2):112\u201320.","journal-title":"Appl Neuropsychol Child"},{"key":"395_CR17","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1038\/tp.2013.34","volume":"3","author":"MJ Bakermans-Kranenburg","year":"2013","unstructured":"Bakermans-Kranenburg MJ, van Ijzendoorn MH. Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy. Transl Psychiatry. 2013;3:e258. https:\/\/doi.org\/10.1038\/tp.2013.34.","journal-title":"Transl Psychiatry"},{"issue":"5","key":"395_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00115-010-3239-6","volume":"82","author":"T Banaschewski","year":"2011","unstructured":"Banaschewski T, Poustka L, Holtmann M. Autismus und ADHS \u00fcber die Lebensspanne. Differenzialdiagnosen oder Komorbidit\u00e4t? [Autism and ADHD across the life span. Differential diagnoses or comorbidity?]. Nervenarzt. 2011;82(5):573\u201380. https:\/\/doi.org\/10.1007\/s00115-010-3239-6.","journal-title":"Nervenarzt"},{"key":"395_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/978-3-030-23563-5_4","volume-title":"Universal access in human-computer interaction. Multimodality and assistive environments","author":"B Banire","year":"2019","unstructured":"Banire B, Al Thani D, Makki M, Qaraqe M, Anand K, Olcay C, Khowaja K, Mansoor B. Attention assessment: Evaluation of facial expressions of children with autism spectrum disorder. In. In: Universal access in human-computer interaction. Multimodality and assistive environments. Berlin Heidelberg: Springer; 2019. pp. 32\u201348. https:\/\/doi.org\/10.1007\/978-3-030-23563-5_4."},{"key":"395_CR20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/978-3-030-30402-7_26","volume-title":"Advances in neurobiology","author":"B Banire","year":"2020","unstructured":"Banire B, Khowaja K, Mansoor B, Qaraqe M, Al Thani D. Reality-based technologies for children with autism spectrum disorder: a\u00a0recommendation for food intake intervention. In: Advances in neurobiology. Berlin Heidelberg: Springer; 2020. pp. 679\u201393. https:\/\/doi.org\/10.1007\/978-3-030-30402-7_26."},{"issue":"1","key":"395_CR21","first-page":"20","volume":"23","author":"DA Baribeau","year":"2014","unstructured":"Baribeau DA, Anagnostou E. Social communication is an emerging target for pharmacotherapy in autism spectrum disorder \u2013 a\u00a0review of the literature on potential agents. J\u00a0Can Acad Child Adolesc Psychiatry. 2014;23(1):20\u201330.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"395_CR22","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0079-6123(08)00435-4","volume":"170","author":"JA Bartz","year":"2008","unstructured":"Bartz JA, Hollander E. Oxytocin and experimental therapeutics in autism spectrum disorders. Prog Brain Res. 2008;170:451\u201362.","journal-title":"Prog Brain Res"},{"key":"395_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1023\/A:1010799115457","volume":"31","author":"KM Belsito","year":"2001","unstructured":"Belsito KM, Law PA, Kirk KS, Landa RJ, Zimmerman AW. Lamotrigine therapy for autistic disorder: a\u00a0randomized, double-blind, placebo-controled trial. J\u00a0Autism Dev Disord. 2001;31:175\u201381.","journal-title":"J Autism Dev Disord"},{"key":"395_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/NDT.S120509","volume":"14","author":"FM Besag","year":"2017","unstructured":"Besag FM. Epilepsy in patients with autism: links, risks and treatment challenges. NDT. 2017;14:1\u201310. https:\/\/doi.org\/10.2147\/NDT.S120509.","journal-title":"NDT"},{"issue":"2","key":"395_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ab.21467","volume":"39","author":"KL Bierman","year":"2013","unstructured":"Bierman KL, Coie J, Dodge K, Greenberg M, Lochman J, McMohan R, et al. School outcomes of aggressive-disruptive children: prediction from kindergarten risk factors and impact of the fast track prevention program. Aggr Behav. 2013;39(2):114. https:\/\/doi.org\/10.1002\/ab.21467.","journal-title":"Aggr Behav"},{"issue":"1","key":"395_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/phar.1686","volume":"36","author":"AB Blackmer","year":"2016","unstructured":"Blackmer AB, Feinstein JA. Management of sleep disorders in children with neurodevelopmental disorders: A\u00a0review. Pharmacotherapy. 2016;36(1):84\u201398. https:\/\/doi.org\/10.1002\/phar.1686.","journal-title":"Pharmacotherapy"},{"issue":"491","key":"395_CR27","doi-asserted-by":"publisher","first-page":"eaat7838","DOI":"10.1126\/scitranslmed.aat7838","volume":"11","author":"F Bolognani","year":"2019","unstructured":"Bolognani F, Del Valle Rubido M, Squassante L, Wandel C, Derks M, Murtagh L, et al. A\u00a0phase 2 clinical trial of a\u00a0vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder. Sci Transl Med. 2019;11(491):eaat7838. https:\/\/doi.org\/10.1126\/scitranslmed.aat7838.","journal-title":"Sci Transl Med"},{"issue":"2","key":"395_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40272-014-0106-0","volume":"17","author":"K Bowers","year":"2015","unstructured":"Bowers K, Lin PI, Erickson C. Pharmacogenomic medicine in autism: challenges and opportunities. Paediatr Drugs. 2015;17(2):115\u201324.","journal-title":"Paediatr Drugs"},{"key":"395_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuropharm.2014.06.028","volume":"88","author":"S Braat","year":"2015","unstructured":"Braat S, Kooy RF. Insights into GABA\u2011A ergic system deficits in fragile X syndrome lead to clinical trials. Neuropharmacology. 2015;88:48\u201354.","journal-title":"Neuropharmacology"},{"issue":"15","key":"395_CR30","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3109\/09638288.2012.723788","volume":"35","author":"CA Brown","year":"2013","unstructured":"Brown CA, Kuo M, Phillips L, Berry R, Tan M. Non-pharmacological sleep interventions for youth with chronic health conditions: A\u00a0critical review of the methodological quality of the evidence. Disab Rehab. 2013;35(15):1221\u201355. https:\/\/doi.org\/10.3109\/09638288.2012.723788.","journal-title":"Disab Rehab"},{"issue":"1","key":"395_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.21037\/tp.2017.08.02","volume":"7","author":"KA Brown","year":"2018","unstructured":"Brown KA, Samuel S, Patel DR. Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a\u00a0review for practitioners. Translat Pediatr. 2018;7(1):36\u201347. https:\/\/doi.org\/10.21037\/tp.2017.08.02.","journal-title":"Translat Pediatr"},{"issue":"2","key":"395_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejpn.2014.12.007","volume":"19","author":"O Bruni","year":"2015","unstructured":"Bruni O, Alonso-Alconada D, Besag F, Biran V, Braam W, Cortese\u00a0S, et al. Current role of melatonin in pediatric neurology: clinical recommendations. Eur J Paed Neurol. 2015;19(2):122\u201333. https:\/\/doi.org\/10.1016\/j.ejpn.2014.12.007.","journal-title":"Eur J Paed Neurol"},{"key":"395_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.coph.2014.11.008","volume":"20","author":"N Burnashev","year":"2015","unstructured":"Burnashev N, Szepetowski P. NMDA receptor subunit mutations in neurodevelopmental disorders. Curr Opin Pharmacol. 2015;20:73\u201382.","journal-title":"Curr Opin Pharmacol"},{"issue":"Article 61","key":"395_CR34","first-page":"1","volume":"2","author":"R Canitano","year":"2014","unstructured":"Canitano R. New experimental treatments for core social domain in autism spectrum disorders. Front Pediatr. 2014;2(Article 61):1\u20136.","journal-title":"Front Pediatr"},{"issue":"1","key":"395_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pnpbp.2010.10.015","volume":"35","author":"R Canitano","year":"2011","unstructured":"Canitano R, Scandurra V. Psychopharmacology in autism: an update. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(1):18\u201328.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"395_CR36","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.acap.2013.04.003","volume":"13","author":"PS Carbone","year":"2013","unstructured":"Carbone PS. Moving from research to practice in the primary care of children with autism spectrum disorders. Acad Pediatr. 2013;13(5):390\u20139. https:\/\/doi.org\/10.1016\/j.acap.2013.04.003.","journal-title":"Acad Pediatr"},{"issue":"4","key":"395_CR37","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3390\/s20040966","volume":"20","author":"S Carlier","year":"2020","unstructured":"Carlier S, Van der Paelt S, Ongenae F, De Backere F, De Turck. Empowering children with ASD and their parents: design of a\u00a0serious game for anxiety and stress reduction. Sensors. 2020;20(4):966. https:\/\/doi.org\/10.3390\/s20040966.","journal-title":"Sensors"},{"key":"395_CR38","doi-asserted-by":"crossref","unstructured":"Hoglund Carlsson L, Norrelgen F, Kjellmer L, Westerlund J, Gillberg C, Fernell E. Coexisting disorders and problems in preschool children with autism spectrum disorders. Sci World\u00a0J. 2013;213979. https:\/\/doi.org\/10.1155\/2013\/213979.","DOI":"10.1155\/2013\/213979"},{"issue":"6","key":"395_CR39","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/cch.12255","volume":"41","author":"AJ Cerrillo-Urbina","year":"2015","unstructured":"Cerrillo-Urbina AJ, Garc\u00eda-Hermoso A, S\u00e1nchez-L\u00f3pez M, Pardo-Guijarro MJ, Santos G\u00f3mez JL, Mart\u00ednez-Vizca\u00edno V. The effects of physical exercise in children with attention deficit hyperactivity disorder: a\u00a0systematic review and meta-analysis of randomized control trials. Child Care Health Dev. 2015;41(6):779\u201388. https:\/\/doi.org\/10.1111\/cch.12255.","journal-title":"Child Care Health Dev"},{"key":"395_CR40","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev.psych.52.1.685","volume":"52","author":"DL Chambless","year":"2001","unstructured":"Chambless DL, Ollendick TH. Empirically supported psychological interventions: controversies and evidence. Annu Rev Psychol. 2001;52:685\u2013716.","journal-title":"Annu Rev Psychol"},{"issue":"5","key":"395_CR41","doi-asserted-by":"publisher","first-page":"e1584","DOI":"10.1542\/peds.2012-0974","volume":"131","author":"A Charach","year":"2013","unstructured":"Charach A, Carson P, Fox S, Ali MU, Beckett J, Lim CG. Interventions for preschool children at high risk for ADHD: a comparative effectiveness review. Pediatrics. 2013;131(5):e1584\u2013e604.","journal-title":"Pediatrics"},{"issue":"5","key":"395_CR42","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1345\/aph.1G389","volume":"40","author":"B Chavez","year":"2006","unstructured":"Chavez B, Chavez-Brown M, Rey JA. Role of risperidone in children with autism spectrum disorder. Ann Pharmacother. 2006;40(5):909\u201316.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"395_CR43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2165\/00148581-200709040-00006","volume":"9","author":"B Chavez","year":"2007","unstructured":"Chavez B, Chavez-Brown M, Sopko MA Jr., Rey JA. Atypical antipsychotics in children with pervasive developmental disorders. Paediatr Drugs. 2007;9(4):249\u201366.","journal-title":"Paediatr Drugs"},{"key":"395_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijdevneu.2014.03.006","volume":"35","author":"J Chen","year":"2014","unstructured":"Chen J, Alberts I, Li X. Dysregulation of the IGF-I\/PIeK\/AKT\/TOR signaling pathway in autism spectrum disorders. Int J Dev Neurosci. 2014;35:35\u201341. https:\/\/doi.org\/10.1016\/j.ijdevneu.2014.03.006.","journal-title":"Int J Dev Neurosci"},{"key":"395_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007849.pub2","author":"DK Cheuk","year":"2011","unstructured":"Cheuk DK, Wong V, Chen WX. Acupuncture for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2011; https:\/\/doi.org\/10.1002\/14651858.CD007849.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"395_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009043.pub2","author":"H Ching","year":"2012","unstructured":"Ching H, Pringsheim T. Aripiprazole for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2012; https:\/\/doi.org\/10.1002\/14651858.CD009043.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"395_CR47","doi-asserted-by":"crossref","unstructured":"Chini B, Leoncino M, Gigliucci V. Oxytocin in the developing brain: Relevance as disease-modifying treatment in autism spectrum disorders. In Carlo Sala and Chiara Verpelli, editors, Neu Syn Dysfunct Autism Spect Dis Intellect Disab. 2016;253\u2013266. London, San Diego, Oxford: Academic Press.","DOI":"10.1016\/B978-0-12-800109-7.00016-9"},{"issue":"7","key":"395_CR48","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/pch\/pxy111","volume":"23","author":"B Clark","year":"2018","unstructured":"Clark B, B\u00e9langer SA. ADHD in children and youth: part 3\u2011assessment and treatment with comorbid ASD, ID, or prematurity. Paediatr Child Health. 2018;23(7):485\u201390. https:\/\/doi.org\/10.1093\/pch\/pxy111.","journal-title":"Paediatr Child Health"},{"issue":"3","key":"395_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5014\/ajot.2019.733001","volume":"73","author":"GF Clark","year":"2019","unstructured":"Clark GF, Watling R, Parham LD, Schaaf R. Occupational therapy interventions for children and youth with challenges in sensory integration and sensory processing: A\u00a0school-based practice case example. Am J Occupat Ther. 2019;73(3):7303390010p1\u20137303390010p8. https:\/\/doi.org\/10.5014\/ajot.2019.733001.","journal-title":"Occupational"},{"issue":"3","key":"395_CR50","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/mp.2015.12","volume":"21","author":"TK Clarke","year":"2015","unstructured":"Clarke TK, Lupton MK, Fernandez-Pujals AM, Starr J, Davies G, Cox S, et al. Common polygenic risk for autism spectrum disorder (ASD) is associated with cognitive ability in the general population. Mol Psychiatry. 2015;21(3):419\u201325. https:\/\/doi.org\/10.1038\/mp.2015.12.","journal-title":"Mol Psychiatry"},{"key":"395_CR51","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.biopsych.2013.10.005","volume":"76","author":"DR Coghill","year":"2014","unstructured":"Coghill DR, Seth S, Pedroso S, Usala T, Currie J, Gagliano A. Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit\/hyperactivity disorder: evidence from a\u00a0systematic review and a\u00a0meta-analysis. Biol Psychiatry. 2014;76:603\u201315. https:\/\/doi.org\/10.1016\/j.biopsych.2013.10.005.","journal-title":"Biol Psychiatry"},{"issue":"7","key":"395_CR52","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40263-017-0443-y","volume":"31","author":"DR Coghill","year":"2017","unstructured":"Coghill DR, Banaschewski T, Nagy P, Hern\u00e1ndez Otero I, Soutullo C, Yan B, et al. Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with ADHD: A\u00a0phase IV, 2\u2011year, open-label study in Europe. CNS Drugs. 2017;31(7):625\u201338. https:\/\/doi.org\/10.1007\/s40263-017-0443-y.","journal-title":"CNS Drugs"},{"issue":"2","key":"395_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/cap.2018.0121","volume":"29","author":"DM Coleman","year":"2019","unstructured":"Coleman DM, Adams JB, Anderson AL, Frye RE. Rating of the effectiveness of 26 psychiatric and seizure medications for autism spectrum disorder: results of a\u00a0national survey. J\u00a0Child Adolesc Psychopharmacol. 2019;29(2):107\u201323. https:\/\/doi.org\/10.1089\/cap.2018.0121.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"395_CR54","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejps.2016.04.026","volume":"89","author":"E Comiran","year":"2016","unstructured":"Comiran E, Kessler FH, Froehlich PE, Limberger RP. Lisdexamfetamine: A\u00a0pharmacokinetic review. Eur J Pharmaceut Sci. 2016;89:172\u2013179. https:\/\/doi.org\/10.1016\/j.ejps.2016.04.026.","journal-title":"J Pharmaceut Sci"},{"issue":"1","key":"395_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1467-8624.2010.01558.x","volume":"82","author":"Conduct Problems Prevention Research Group.","year":"2011","unstructured":"Conduct Problems Prevention Research Group. The effects of the Fast Track preventive intervention on the development of conduct disorder across childhood. Child Dev. 2011;82(1):331\u201345. https:\/\/doi.org\/10.1111\/j.1467-8624.2010.01558.x.","journal-title":"Child Dev"},{"issue":"3","key":"395_CR56","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jaac.2014.12.010","volume":"54","author":"S Cortese","year":"2015","unstructured":"Cortese S, Ferrin M, Brandeis D, Buitelaar J, Daley D, Dittmann RW, et al. Cognitive training for attention-deficit\/hyperactivity disorder: Meta- analysis of clinical and neuropsychological outcomes from randomized controlled trials. J\u00a0Am Acad Child Adoles Psych. 2015;54(3):164\u2013174. https:\/\/doi.org\/10.1016\/j.jaac.2014.12.010.","journal-title":"J\u00a0Am Acad Child Adoles Psych."},{"issue":"7","key":"395_CR57","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.sleep.2010.01.010","volume":"11","author":"F Cortesi","year":"2011","unstructured":"Cortesi F, Giannotti F, Ivanenko A, Johnson K. Sleep in children with autistic spectrum disorder. Sleep\u00a0M. 2011;11(7):659\u201364. https:\/\/doi.org\/10.1016\/j.sleep.2010.01.010.","journal-title":"Sleep M"},{"issue":"1","key":"395_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejpn.2018.10.005","volume":"23","author":"F Craig","year":"2019","unstructured":"Craig F, Savino R, Trabacca A. A\u00a0systematic review of comorbidity between cerebral palsy, autism spectrum disorders and attention deficit hyperactivity disorder. Eur J Paediatr Neurol. 2019;23(1):31\u201342. https:\/\/doi.org\/10.1016\/j.ejpn.2018.10.005.","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"395_CR59","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/MCP.0b013e328365ab07","volume":"19","author":"Y Dauvilliers","year":"2013","unstructured":"Dauvilliers Y, Winkelmann J. Restless legs syndrome: update on pathogenesis. Curr Opinoion Pulm Med. 2013;19(6):594\u2013600. https:\/\/doi.org\/10.1097\/MCP.0b013e328365ab07.","journal-title":"Curr Opinoion Pulm Med"},{"issue":"6","key":"395_CR60","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/MOP.0b013e32834cf082","volume":"23","author":"G Dawson","year":"2011","unstructured":"Dawson G, Burner K. Behavioral interventions in children and adolescents with autism spectrum disorder: a\u00a0review of recent findings. Curr Opin Pediatr. 2011;23(6):616\u201320.","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"395_CR61","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.eurpsy.2010.09.011","volume":"26","author":"M De Hert","year":"2011","unstructured":"De Hert M, Dobbelaere M, Sheridan EM, Cohen D, Correll CU. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice. Eur psychiatr. 2011;26(3):144\u201358.","journal-title":"Eur psychiatr"},{"issue":"3","key":"395_CR62","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ridd.2013.12.004","volume":"35","author":"S Deb","year":"2014","unstructured":"Deb S, Farmah BK, Arshad E, Deb T, Roy M, Unwin GL. The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and\/or autistic spectrum disorder\u2013a\u00a0systematic review. Res Dev Disabil. 2014;35(3):711\u201325.","journal-title":"Res Dev Disabil"},{"issue":"4","key":"395_CR63","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4103\/1817-1745.174438","volume":"10","author":"PA Devnani","year":"2015","unstructured":"Devnani PA, Hegde AU. Autism and sleep disorders. J\u00a0Pediatr Neurosci. 2015;10(4):304\u20137.","journal-title":"J Pediatr Neurosci"},{"issue":"1","key":"395_CR64","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1517\/17425255.2015.981151","volume":"11","author":"M Dinissen","year":"2015","unstructured":"Dinissen M, Dietrich A, van den Hoofdakker BJ, Hoekstra. Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder. Expert Opin Drug Metab Toxicol. 2015;11(1):111\u201324.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"395_CR65","unstructured":"Dolle K, Schulte-K\u00f6rne G. Evidenztabelle Psycho- und Pharmakotherapie im Vergleich und in Kombination zur Leitlinie \u201eBehandlung von depressiven St\u00f6rungen bei Kindern und Jugendlichen\u201c [Table of evidence Psycho- and pharmacotherapy, comparing and combining the guideline Treatment of depressive disorders in children and adolescents. 2012. http:\/\/www.awmf.org\/leitlinien\/aktuelle-leitlinien.html. Accessed: 17 Jun 2021."},{"issue":"3","key":"395_CR66","first-page":"143","volume":"12","author":"P Douglas-Hall","year":"2011","unstructured":"Douglas-Hall P, Curran S, Bird V, Taylor D. Aripiprazole: a\u00a0review of its use in the treatment of irritability associated with autistic disorder patients aged 6\u201317. J\u00a0Cent Nerv Syst Disord. 2011;12(3):143\u201353.","journal-title":"J Cent Nerv Syst Disord"},{"issue":"4","key":"395_CR67","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1542\/peds.2012-0683","volume":"130","author":"D Dove","year":"2012","unstructured":"Dove D, Warren Z, McPheeters ML, Taylor JL, Sathe NA, Veenstra-VanderWeele J. Medications for adolescents and young adults with autism spectrum disorders: a\u00a0systematic review. Pediatrics. 2012;130(4):717\u201326, 2012. https:\/\/doi.org\/10.1542\/peds.2012-0683.","journal-title":"Pediatrics"},{"issue":"3","key":"395_CR68","first-page":"263","volume":"14","author":"CA Doyle","year":"2012","unstructured":"Doyle CA, McDougle CJ. Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan. Dia Clin Neurosci. 2012;14(3):263\u201379, 2012.","journal-title":"Neurosci."},{"key":"395_CR69","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/cap.2006.00136","volume":"2","author":"HS Duggal","year":"2007","unstructured":"Duggal HS. Ziprasidone for maladaptive behavior and attention-deficit\/hyperactivity disorder symptoms in autistic disorder. J\u00a0Child Adolesc Psychopharmacol. 2007;2:261\u20133.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"395_CR70","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.chc.2014.05.003","volume":"23","author":"GJ DuPaul","year":"2014","unstructured":"DuPaul GJ, Gormley MJ, Laracy SD. School-based interventions for elementary school students with ADHD. Child Adolescent Psych Clin N\u00a0Am. 2014;23(4):687\u201397. https:\/\/doi.org\/10.1016\/j.chc.2014.05.003.","journal-title":"Am"},{"issue":"6","key":"395_CR71","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.ridd.2012.06.015","volume":"33","author":"TT Dyches","year":"2012","unstructured":"Dyches TT, Smith TB, Korth BB, Roper SO, Mandleco B. Positive parenting of children with developmental disabilities: a\u00a0meta-analysis. Res Develop Disabil. 2012;33(6):2213\u201320. https:\/\/doi.org\/10.1016\/j.ridd.2012.06.015.","journal-title":"Res Develop Disabil"},{"issue":"2","key":"395_CR72","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/jcap.12144","volume":"29","author":"JF Earle","year":"2016","unstructured":"Earle JF. An introduction to the psychopharmacology of children and adolescents with autism spectrum disorder. J\u00a0Child Adoles Psych Nurs. 2016;29(2):62\u201371. https:\/\/doi.org\/10.1111\/jcap.12144.","journal-title":"J\u00a0Child Adoles Psych Nurs."},{"issue":"3","key":"395_CR73","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/aur.239","volume":"5","author":"M Elsabbagh","year":"2012","unstructured":"Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcin C, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res. 2012;5(3):160\u201379. https:\/\/doi.org\/10.1002\/aur.239.","journal-title":"Autism Res."},{"key":"395_CR74","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1046\/j.1528-1157.2001.10401.x","volume":"42","author":"J Engel Jr.","year":"2001","unstructured":"Engel J Jr. A\u00a0proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ilae task force on classification and terminology. Epilepsia. 2001;42:796\u2013803.","journal-title":"Epilepsia"},{"key":"395_CR75","unstructured":"Epstein R, Fonnesbeck C, Williamson E, Kuhn T, Lindegren ML, Rizzone K, Krishnaswami S, Sathe N, Ficzere CH, Ness GL, Wright GW, Raj M, Potter S, McPheeters M. Psychosocial and pharmacologic interventions for disruptive behavior in children and adolescents. comparative effectiveness review number 154. 2015. https:\/\/effectivehealthcare.ahrq.gov\/sites\/default\/files\/pdf\/disruptive-beha vior-disorder_research.pdf. Accessed: 17 Jun 2021"},{"issue":"5","key":"395_CR76","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1542\/peds.2015-2577","volume":"136","author":"RA Epstein","year":"2015","unstructured":"Epstein RA, Fonnesbeck C, Potter S, Rizzone KH, McPheeters M. Psychosocial interventions for child disruptive behaviors: a meta-analysis. Pediatrics. 2015;136(5):947\u201360. https:\/\/doi.org\/10.1542\/peds.2015-2577.","journal-title":"Pediatrics"},{"issue":"4","key":"395_CR77","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s10803-013-1963-z","volume":"44","author":"CA Erickson","year":"2014","unstructured":"Erickson CA, Veenstra-Vanderweele JM, Melmed RD, McCracken JT, Ginsberg LD, Sikich L, et al. Stx209 (Arbaclofen) for autism spectrum disorders: an 8\u2011week open-label study. J\u00a0Autism Dev Disord. 2014;44(4):958\u201364. https:\/\/doi.org\/10.1007\/s10803-013-1963-z.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"395_CR78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/10673220490425924","volume":"12","author":"CL Ernst","year":"2004","unstructured":"Ernst CL, Goldberg JF. Antisuicide properties of psychotropic drugs: a\u00a0critical review. Harv Rev Psychiatry. 2004;12(1):14\u201341. https:\/\/doi.org\/10.1080\/10673220490425924.","journal-title":"Harv Rev Psychiatry"},{"issue":"2","key":"395_CR79","first-page":"187","volume":"28","author":"M Ernst","year":"1992","unstructured":"Ernst M, Magee HJ, Gonzalez NM, Locascio JJ, Rosenberg CR, Campbell M. Pimozide in autistic children. Psychopharmacol Bull. 1992;28(2):187\u201391.","journal-title":"Psychopharmacol Bull"},{"issue":"2","key":"395_CR80","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/15374416.2017.1390757","volume":"47","author":"SW Evans","year":"2018","unstructured":"Evans SW, Owens JS, Wymbs BT, Ray AR. Evidence-based psychosocial treatments for children and adolescents with attention deficit\/hyperactivity disorder. J\u00a0Clin Child Adolesc Psychol. 2018;47(2):157\u201398. https:\/\/doi.org\/10.1080\/15374416.2017.1390757.","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"4","key":"395_CR81","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40265-013-0021-7","volume":"73","author":"C Farmer","year":"2013","unstructured":"Farmer C, Thurm A, Grant P. Pharmacotherapy for the core symptoms in autistic disorder: current status of the research. Drugs. 2013;73(4):303\u201314. https:\/\/doi.org\/10.1007\/s40265-013-0021-7.","journal-title":"Drugs."},{"issue":"4","key":"395_CR82","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1517\/14656566.2011.557661","volume":"12","author":"CA Farmer","year":"2011","unstructured":"Farmer CA, Aman MG. Aripiprazole for the treatment of irritability associated with autism. Expert Opin Pharmacother. 2011;12(4):635\u201340.","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"395_CR83","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/phar.1201","volume":"33","author":"MA Faulkner","year":"2013","unstructured":"Faulkner MA, Singh SP. Neurogenetic disorders and treatment of associated seizures. Pharmacotherapy. 2013;33(3):330\u201343. https:\/\/doi.org\/10.1002\/phar.1201.","journal-title":"Pharmacotherapy"},{"key":"395_CR84","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.smrv.2019.04.012","volume":"46","author":"SM Faulkner","year":"2019","unstructured":"Faulkner SM, Bee PE, Meyer N, Dijk DJ, Drake RJ. Light therapies to improve sleep in intrinsic circadian rhythm sleep disorders and neuro-psychiatric illness: a systematic review and meta-analysis. Sleep Med Rev. 2019;46:108\u201323. https:\/\/doi.org\/10.1016\/j.smrv.2019.04.012.","journal-title":"Sleep Med Rev"},{"key":"395_CR85","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/pch\/pxy113","volume":"23","author":"ME Feldman","year":"2018","unstructured":"Feldman ME, Charach A, B\u00e9langer SA. ADHD in children and youth: part 2\u2014treatment. Paediatr Child Health. 2018;23:462\u201372. https:\/\/doi.org\/10.1093\/pch\/pxy113.","journal-title":"Paediatr Child Health"},{"key":"395_CR86","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/clep.s41714","volume":"5","author":"E Fernell","year":"2013","unstructured":"Fernell E, Eriksson MA, Gillberg C. Early diagnosis of autism and impact on prognosis: a\u00a0narrative review. Clin Epidemiol. 2013;5:33\u201343. https:\/\/doi.org\/10.2147\/clep.s41714.","journal-title":"Clin Epidemiol"},{"issue":"8","key":"395_CR87","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00787-013-0494-7","volume":"23","author":"M Ferrin","year":"2014","unstructured":"Ferrin M, Moreno-Granados JM, Salcedo-Marin MD, Ruiz-Veguilla M, Perez-Ayala V, Taylor E. Evaluation of a\u00a0psychoeducation programme for parents of children and adolescents with ADHD: Immediate and long-term effects using a\u00a0blind randomized controlled trial. Eur Child Adolesc Psychiatry. 2014;23(8):637\u201347.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"395_CR88","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00608-013-0132-0","volume":"49","author":"T Flatz","year":"2014","unstructured":"Flatz T, Gleu\u00dfner M. Neurofeedbacktherapie bei ADHS und Autismus [neurofeedback therapy for ADHD and Autism]. Paediatr Paedol. 2014;49:22\u20137.","journal-title":"Paediatr Paedol"},{"issue":"2","key":"395_CR89","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1044\/1058-0360(2010\/09-0022","volume":"19","author":"M Flippin","year":"2010","unstructured":"Flippin M, Reszka S, Watson LR. Effectiveness of the picture exchange communication system (PECS) on communication and speech for children with autism spectrum disorders: a\u00a0meta-analysis. Am J Speech Lang Pathol. 2010;19(2):178\u201395. https:\/\/doi.org\/10.1044\/1058-0360(2010\/09-0022).","journal-title":"Am J Speech Lang Pathol"},{"issue":"12","key":"395_CR90","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3928\/00904481-20131122-10","volume":"42","author":"A Francis","year":"2013","unstructured":"Francis A, Msall M, Obringer E, Kelley K. Children with autism spectrum disorder and epilepsy. Pediat Ann. 2013;42(12):255\u201360. https:\/\/doi.org\/10.3928\/00904481-20131122-10.","journal-title":"Pediat Ann"},{"issue":"3","key":"395_CR91","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/cap.2009.0048","volume":"20","author":"TW Frazier","year":"2010","unstructured":"Frazier TW, Youngstrom EA, Haycook T, Sinoff A, Dimitrou F, Knapp J, et al. Effectiveness of medication combined with intensive behavioral intervention for reducing aggression in youth with autism spectrum disorder. J\u00a0Child Adolesc Psychopharmacol. 2010;20(3):167\u201377.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"395_CR92","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1089\/cap.2011.0057","volume":"21","author":"TW Frazier","year":"2011","unstructured":"Frazier TW, Shattuck PT, Narendorf SC, Cooper BP, Wagner M, Spitznagel EL. Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit\/hyperactivity disorder. J\u00a0Child Adolesc Pharmacol. 2011;21(6):571\u20139. https:\/\/doi.org\/10.1089\/cap.2011.0057.","journal-title":"J Child Adolesc Pharmacol"},{"issue":"2","key":"395_CR93","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0013-7006(07)91549-3","volume":"33","author":"T Fr\u00e9maux","year":"2007","unstructured":"Fr\u00e9maux T, Reymann JM, Chevreuil C, Bentu\u00e9-Ferrer D. Prescription de l\u2019olanzapine chez l\u2019enfant et l\u2019adolescent [Verschreibung von Olanzapin bei Kindern und Jugendlichen]. Encephale. 2007;33(2):188\u201396.","journal-title":"Encephale"},{"issue":"8","key":"395_CR94","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40263-018-0556-y","volume":"32","author":"RE Frye","year":"2018","unstructured":"Frye RE. Social skills deficits in autism spectrum disorder: potential biological origins and progress in developing therapeutic agents. CNS Drugs. 2018;32(8):713\u201334. https:\/\/doi.org\/10.1007\/s40263-018-0556-y.","journal-title":"CNS Drugs"},{"key":"395_CR95","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2431-11-37","volume":"11","author":"RE Frye","year":"2011","unstructured":"Frye RE, Sreenivasula S, Adams JB. Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey. BMC Pediatr. 2011;11:37.","journal-title":"BMC Pediatr"},{"issue":"31","key":"395_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2013.00031","volume":"1","author":"RE Frye","year":"2013","unstructured":"Frye RE, Rossignol D, Casanova MF, Brown GL, Martin V, Edelson S, et al. A\u00a0review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a\u00a0systematic review and expert panel. Front Public Health. 2013;1(31):1\u201326. https:\/\/doi.org\/10.3389\/fpubh.2013.00031.","journal-title":"Front Public Health"},{"key":"395_CR97","doi-asserted-by":"crossref","unstructured":"Gaastra GF, Groen Y, Tucha L, Tucha O. The effects of classroom interventions on off-task and disruptive classroom behavior in children with symptoms of attention-deficit\/hyperactivity disorder: A meta-analytic review. PLOS ONE. 2016;11(2):e0148841:1\u201319. https:\/\/doi.org\/10.1371\/journal.pone.0148841.","DOI":"10.1371\/journal.pone.0148841"},{"issue":"5","key":"395_CR98","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/DDDT.S17266","volume":"11","author":"M Gahr","year":"2011","unstructured":"Gahr M, K\u00f6lle MA, Sch\u00f6nfeldt-Lecuona C, Lepping P, Freudenmann RW. Paliperidone extended-release: does it have a\u00a0place in antipsychotic therapy? DDDT. 2011;11(5):125\u201346.","journal-title":"DDDT"},{"issue":"2","key":"395_CR99","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/1566524015666150303003028","volume":"15","author":"R Gao","year":"2015","unstructured":"Gao R, Penzes P. Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. Curr Molec Med. 2015;15(2):146\u201367. https:\/\/doi.org\/10.2174\/1566524015666150303003028.","journal-title":"Curr Molec Med"},{"key":"395_CR100","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.phrs.2018.07.010","volume":"140","author":"VR Garbarino","year":"2019","unstructured":"Garbarino VR, Lee Gilman T, Daws LC, Gould GG. Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder. Pharmacol Res. 2019;140:85\u201399. https:\/\/doi.org\/10.1016\/j.phrs.2018.07.010.","journal-title":"Pharmacol Res"},{"key":"395_CR101","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.cpr.2017.01.006","volume":"52","author":"JA Gates","year":"2017","unstructured":"Gates JA, Kang E, Lerner MD. Efficacy of group social skills interventions for youth with autism spectrum disorder: a\u00a0systematic review and meta-analysis. Clin Psychol Rev. 2017;52:164\u201381. https:\/\/doi.org\/10.1016\/j.cpr.2017.01.006.","journal-title":"Clin Psychol Rev"},{"issue":"2","key":"395_CR102","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tics.2008.11.006","volume":"13","author":"HM Geurts","year":"2009","unstructured":"Geurts HM, Corbett B, Solomon M. The paradox of cognitive flexibility in autism. Trends Cogn Sci. 2009;13(2):74\u201382. https:\/\/doi.org\/10.1016\/j.tics.2008.11.006.","journal-title":"Trends Cogn Sci"},{"issue":"2","key":"395_CR103","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10578-013-0390-x","volume":"45","author":"A Ghanizadeh","year":"2014","unstructured":"Ghanizadeh A, Sahraeizadeh A, Berk M. A\u00a0head-to-head comparison of Aripiprazole and Risperidone for safety and treating autistic disorders, a\u00a0randomized double blind clinical trial. Child Psychiatry Hum Dev. 2014;45(2):185\u201392.","journal-title":"Child Psychiatry Hum Dev"},{"key":"395_CR104","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2147\/ndt.s194022","volume":"15","author":"A Ghanizadeh","year":"2019","unstructured":"Ghanizadeh A, Molla MAS, Olango GJ. The effect of stimulants on irritability in autism comorbid with ADHD: a\u00a0systematic review. Neuropsych Dis Treat. 2019;15:1547\u201355. https:\/\/doi.org\/10.2147\/ndt.s194022.","journal-title":"Neuropsych Dis Treat"},{"issue":"3","key":"395_CR105","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.yebeh.2012.11.002","volume":"26","author":"KL Gilby","year":"2013","unstructured":"Gilby KL, O\u2019Brien TJ. Epilepsy, autism, and neurodevelopment: kindling a\u00a0shared vulnerability? Epilepsy Behav. 2013;26(3):370\u20134. https:\/\/doi.org\/10.1016\/j.yebeh.2012.11.002.","journal-title":"Epilepsy Behav"},{"issue":"4","key":"395_CR106","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/1362361314526003","volume":"19","author":"E Gjevik","year":"2014","unstructured":"Gjevik E, Sandstad B, Andreassen OA, Myhre AM, Sponheim E. Exploring the agreement between questionnaire information and DSM-IV diagnoses of comorbid psychopathology in children with autism spectrum disorders. Autism. 2014;19(4):433\u201342. https:\/\/doi.org\/10.1177\/1362361314526003.","journal-title":"Autism"},{"issue":"1","key":"395_CR107","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/09540261.2018.1458706","volume":"30","author":"R Goel","year":"2018","unstructured":"Goel R, Hong JS, Findling RL, Ji NY. An update on pharmacotherapy of autism spectrum disorder in children and adolescents. Int Rev Psych. 2018;30(1):78\u201395. https:\/\/doi.org\/10.1080\/09540261.2018.1458706.","journal-title":"Int Rev Psych"},{"key":"395_CR108","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s10803-014-2123-9","volume":"44","author":"SE Goldman","year":"2014","unstructured":"Goldman SE, Adkins KW, Calcutt MW, Carter MD, Goodpaster RL, Wang L, et al. Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep. J\u00a0Autism Dev Disord. 2014;44:2525\u201335.","journal-title":"J Autism Dev Disord"},{"issue":"6","key":"395_CR109","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/WNF.0b013e31823349ac","volume":"34","author":"P Golubchik","year":"2011","unstructured":"Golubchik P, Sever J, Weizman A. Low-dose quetiapine for adolescents with autistic spectrum disorder and aggressive behavior: open-label trial. Clin Neuropharmacol. 2011;34(6):216\u20139.","journal-title":"Clin Neuropharmacol"},{"key":"395_CR110","volume-title":"Handbuch der Psychopharmakatherapie [Handbook of Psychopharmacotherapy]","author":"G Gr\u00fcnder","year":"2008","unstructured":"Gr\u00fcnder G, Benkert O. Handbuch der Psychopharmakatherapie [Handbook of Psychopharmacotherapy]. Heidelberg: Springer; 2008."},{"issue":"7","key":"395_CR111","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","volume":"67","author":"AJ Guastella","year":"2010","unstructured":"Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ, et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry. 2010;67(7):692\u20134.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"395_CR112","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.psyneuen.2012.11.019","volume":"38","author":"AJ Guastella","year":"2013","unstructured":"Guastella AJ, Hickie IB, McGuiness MM, Otis M, Woods EA, Disinger HM, et al. Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology. 2013;38(5):612\u201325.","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"395_CR113","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.biopsych.2015.06.028","volume":"79","author":"AJ Guastella","year":"2015","unstructured":"Guastella AJ, Hickie IB. Oxytocin treatment, circuitry and autism: a\u00a0critical review of the literature placing oxytocin into the austism context. Biol Psychiatry. 2015;79(3):234\u201342. https:\/\/doi.org\/10.1016\/j.biopsych.2015.06.028.","journal-title":"Biol Psychiatry"},{"issue":"Supplement 1","key":"395_CR114","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0035-3787(04)71201-1","volume":"160","author":"M Guenot","year":"2004","unstructured":"Guenot M. Indications et risques des techniques neuro-chirurgicales chez l\u2019enfant pr\u00e9sentant une \u00e9pilepsie partielle pharmaco-r\u00e9sistante. [Surgical treatment for epilepsy in children wihth treatment resistant partial epilepsy: indications and complications]. Rev Neurol. 2004;160(Supplement 1):203\u20139.","journal-title":"Rev Neurol"},{"issue":"2","key":"395_CR115","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/JCP.0b013e318285680c","volume":"33","author":"R Guglielmo","year":"2013","unstructured":"Guglielmo R, Ioime L, Grandinetti P, Janiri L. Managing disruptive and compulsive behaviors in adult with autistic disorder with Gabapentin. J\u00a0Clin Psychopharmacol. 2013;33(2):273\u20134.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"395_CR116","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/cap.2015.0167","volume":"26","author":"T Gurnani","year":"2016","unstructured":"Gurnani T, Ivanov I, Newcorn JH. Pharmacotherapy of aggression in child and adolescent psychiatric disorders. J Child Adol Psychopharmacol. 2016;26(1):65\u201373. https:\/\/doi.org\/10.1089\/cap.2015.0167.","journal-title":"Psychopharmacol"},{"issue":"4e0216198","key":"395_CR117","first-page":"1","volume":"14","author":"A Habib","year":"2019","unstructured":"Habib A, Harris L, Pollick F, Melville C. A\u00a0meta-analysis of working memory in individuals with autism spectrum disorders. PLoS ONE. 2019;14(4e0216198):1\u201325.","journal-title":"PLoS ONE"},{"issue":"6","key":"395_CR118","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/0883073808329527","volume":"24","author":"LD Hamiwka","year":"2009","unstructured":"Hamiwka LD, Wirrell EC. Comorbidities in pediatric epilepsy: beyond \u201cjust\u201d treating the seizures. J\u00a0Child Neurol. 2009;24(6):734\u201342.","journal-title":"J Child Neurol"},{"key":"395_CR119","volume-title":"Preschool education programs for children with autism","author":"JS Handleman","year":"2001","unstructured":"Handleman JS, Harris SL. Preschool education programs for children with autism. Austin: ProEd; 2001."},{"issue":"4","key":"395_CR120","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s10803-006-0192-0","volume":"37","author":"E Hanson","year":"2007","unstructured":"Hanson E, Kalish LA, Bunce E, Curtis C, McDaniel S, Ware J, et al. Use of complementary and alternative medicine among children diagnosed with autism spectrum disorder. J\u00a0Autism Dev Disord. 2007;37(4):628\u201336. https:\/\/doi.org\/10.1007\/s10803-006-0192-0.","journal-title":"J Autism Dev Disord"},{"issue":"176","key":"395_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-244X-11-176","volume":"11","author":"R Hanwella","year":"2011","unstructured":"Hanwella\u00a0R, Senanayake M, de\u00a0Silva V. Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a\u00a0meta-analysis. BMC Psychiatry. 2011;11(176):1\u20138. https:\/\/doi.org\/10.1186\/1471-244X-11-176.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"395_CR122","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10803-005-3306-1","volume":"35","author":"AY Hardan","year":"2005","unstructured":"Hardan AY, Jou RJ, Handen BL. Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders. J\u00a0Autism Dev Disord. 2005;35(3):387\u201391.","journal-title":"J Autism Dev Disord"},{"issue":"7","key":"395_CR123","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jaac.2012.04.011","volume":"51","author":"M Harfterkamp","year":"2012","unstructured":"Harfterkamp M, van\u00a0de Loo-Neus G, Minderaa RB, van\u00a0der Gaag RJ, Escobar R, Schacht A, et al. A\u00a0randomized double-blind study of atomoxetine versus placebo for attention-deficit\/hyperactivity disorder symptoms in children with autism spectrum disorder. J\u00a0Am Acad Child Adol Psych. 2012;51(7):733\u201341. https:\/\/doi.org\/10.1016\/j.jaac.2012.04.011.","journal-title":"J\u00a0Am Acad Child Adol Psych."},{"issue":"3","key":"395_CR124","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1089\/cap.2012.0012","volume":"23","author":"M Harfterkamp","year":"2013","unstructured":"Harfterkamp M, Buitelaar JK, Minderaa RB, van de Loo-Neus G, van der Gaag RJ, Hoekstra PJ. Long-term treatment with atomoxetine for attention-deficit\/ hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: An open-label extension study. J\u00a0Child Adolesc Psychopharmacol. 2013;23(3):194\u20139. https:\/\/doi.org\/10.1089\/cap.2012.0012.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"395_CR125","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/1362361309335717","volume":"13","author":"SL Hartley","year":"2009","unstructured":"Hartley SL, Sikora DM. Which DSM-IV-TR criteria best differentiate high-functioning autism spectrum disorder from ADHD and anxiety disorders in older children? Autism. 2009;13(5):485\u2013509. https:\/\/doi.org\/10.1177\/1362361309335717.","journal-title":"Autism"},{"issue":"2","key":"395_CR126","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/01.HRP.0000445143.08773.58","volume":"22","author":"EP Hazen","year":"2014","unstructured":"Hazen EP, Stornelli JL, O\u2019Rourke JA, Koesterer K, McDougle CJ. Sensory symptoms in autism spectrum disorders. Harv Rev Psychiatry. 2014;22(2):112\u201324.","journal-title":"Harv Rev Psychiatry"},{"issue":"6","key":"395_CR127","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0269881113482532","volume":"27","author":"DJ Heal","year":"2013","unstructured":"Heal DJ, Smith SL, Gosden J, Nutt DJ. Amphetamine, past and present\u2013a\u00a0pharmacological and clinical perspective. J\u00a0Psychopharmacol. 2013;27(6):479\u201396. https:\/\/doi.org\/10.1177\/0269881113482532.","journal-title":"J\u00a0Psychopharmacol."},{"issue":"Suppl 1","key":"395_CR128","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s00702-016-1593-7","volume":"124","author":"AE Den Heijer","year":"2017","unstructured":"Den Heijer AE, Groen Y, Tucha L, Fuermaier ABM, Janneke Koerts, Lange KW, et al. Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD: a systematic literature review. J\u00a0Neural Transm. 2017;124(Suppl 1):S3\u2013S26. https:\/\/doi.org\/10.1007\/s00702-016-1593-7.","journal-title":"J Neural Transm"},{"issue":"4","key":"395_CR129","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1089\/cap.2005.15.682","volume":"15","author":"JA Hellings","year":"2005","unstructured":"Hellings JA, Weckbaugh M, Nickel EJ, Cain SE, Zarcone JR, Reese RM, et al. A\u00a0double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. J\u00a0Child Adolesc Psychopharmacol. 2005;15(4):682\u201392. https:\/\/doi.org\/10.1089\/cap.2005.15.682.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"152","key":"395_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.3004218","volume":"4","author":"C Henderson","year":"2012","unstructured":"Henderson C, Wietjunge I, Kinoshita MN, Shumway M, Hammond RS, Postma FR, et al. Reversal of disease-related pathologies in the Fragile X mouse model by selective activation of GABA\u2011B receptors with arbaclofen. Sci Transl Med. 2012;4(152):1\u201311.","journal-title":"Sci Transl Med"},{"issue":"3","key":"395_CR131","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/famp.\/12232","volume":"55","author":"SW Henggeler","year":"2016","unstructured":"Henggeler SW, Schaeffer CM. Multisystemic therapy: clinical overview, outcomes, and implementation research. Fam Proc. 2016;55(3):514\u201328. https:\/\/doi.org\/10.1111\/famp.\/12232.","journal-title":"Fam Proc"},{"issue":"3","key":"395_CR132","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40263-017-0410-7","volume":"31","author":"L Hennissen","year":"2017","unstructured":"Hennissen L, Bakker MJ, Banaschewski T, Carucci S, Coghill D, Danckaerts M, et al. Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: A\u00a0systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine. CNS Drugs. 2017;31(3):199\u2013215. https:\/\/doi.org\/10.1007\/s40263-017-0410-7.","journal-title":"CNS Drugs."},{"issue":"4","key":"395_CR133","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s10803-013-1952-2","volume":"44","author":"T Hirota","year":"2014","unstructured":"Hirota T, Veenstra-Vanderweele J, Hollander E, Kishi T. Antiepileptic medications in autism spectrum disorder: a\u00a0systematic review and meta-analysis. J\u00a0Autism Dev Disord. 2014;44(4):948\u201357.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"395_CR134","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00406-019-00984-4","volume":"269","author":"E Hoch","year":"2019","unstructured":"Hoch E, Niemann D, von Keller R, Schneider M, Friemel CM, Preuss UW, et al. How effective and safe is medical cannabis as a\u00a0treatment of mental disorders? A systematic review. Eur Arch Psychiatry Clin Neurosci. 2019;269(1):87\u2013105. https:\/\/doi.org\/10.1007\/s00406-019-00984-4.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"395_CR135","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/sj.npp.1300627","volume":"30","author":"E Hollander","year":"2005","unstructured":"Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S, et al. A\u00a0placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology. 2005;30(3):582\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"395_CR136","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1017\/S1461145705005791","volume":"9","author":"E Hollander","year":"2006","unstructured":"Hollander E, Soorya L, Wasserman S, Esposito K, Chaplin W, Anagnostou E. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. Int J Neuropsychopharmacol. 2006;9:209\u201313.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"395_CR137","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/cap.2006.16.541","volume":"16","author":"E Hollander","year":"2006","unstructured":"Hollander E, Wasserman S, Swanson EN, Chaplin W, Schapiro ML, Zagursky K, et al. A\u00a0double-blind placebo-controlled pilot study of olanzapine in childhood\/adolescent pervasive developmental disorder. J\u00a0Child Adolesc Psychopharmacol. 2006a;16(5):541\u20138.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"395_CR138","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/j.1469-8749.2011.04043.x","volume":"53","author":"M Holtmann","year":"2011","unstructured":"Holtmann M, Steiner S, Hohmann S, Poustka L, Banaschewski T, B\u00f6telte S. Neurofeedback in autism spectrum disorders. Dev Med Child Neurol. 2011;53:986\u201393. https:\/\/doi.org\/10.1111\/j.1469-8749.2011.04043.x.","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"395_CR139","first-page":"166","volume":"22","author":"S Hosenbocus","year":"2013","unstructured":"Hosenbocus S, Chahal R. Memantine: a\u00a0review of possible uses in child and adolescent psychiatry. J\u00a0Can Acad Child Adolesc Psychiatry. 2013;22(2):166\u201371.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"2","key":"395_CR140","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/HRP.0000000000000029","volume":"22","author":"EY Hsiao","year":"2014","unstructured":"Hsiao EY. Gastrointestinal issues in autism spectrum disorder. Harv Rev Psychiatry. 2014;22(2):104\u201311.","journal-title":"Harv Rev Psychiatry"},{"issue":"2","key":"395_CR141","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/aur.73","volume":"2","author":"VW Hu","year":"2009","unstructured":"Hu VW, Sarachana T, Kim KS, Nguyen A, Kulkarni S, Steinberg ME, et al. Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res. 2009;2(2):78\u201397. https:\/\/doi.org\/10.1002\/aur.73.","journal-title":"Autism Res"},{"issue":"4","key":"395_CR142","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.encep.2014.08.010","volume":"41","author":"G Huguet","year":"2014","unstructured":"Huguet G, Contrejean Y, Doyen C. Troubles du spectre autistique et suicidalit\u00e9. Encephale. 2014;41(4):362\u20139. https:\/\/doi.org\/10.1016\/j.encep.2014.08.010.","journal-title":"Encephale"},{"issue":"3","key":"395_CR143","first-page":"1","volume":"14","author":"R Hurwitz","year":"2012","unstructured":"Hurwitz R, Blackmore R, Hazell P, Williams K, Woolfenden S. Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents. Coch Data Syst Rev. 2012;;14(3):1\u201331, 2012.","journal-title":"Syst Rev"},{"issue":"1","key":"395_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40261-015-0336-0","volume":"36","author":"M Huss","year":"2016","unstructured":"Huss M, Chen W, Ludolph AG. Guanfacine extended release: A new pharmacological treatment option in Europe. Clin Drug Investigat. 2016;36(1):1\u201325. https:\/\/doi.org\/10.1007\/s40261-015-0336-0.","journal-title":"Europe. Clin Drug Investigat."},{"key":"395_CR145","doi-asserted-by":"crossref","unstructured":"Hutson PH, Pennick M, Secker R. Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a\u00a0novel d\u2011amphetamine pro-drug. Neuropharmacology. 2014;87:41\u201350. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.02.014.","DOI":"10.1016\/j.neuropharm.2014.02.014"},{"key":"395_CR146","doi-asserted-by":"crossref","unstructured":"Hyman SL, Levy SE, Myers SM, Councl on Children with Disabilities, Section on Developmental and Behavioral Pediatrics. Identification, evaluation, and management of children with autism spectrum disorders. Pediatrics. 2019;145(1):e20193447:1\u201364. https:\/\/doi.org\/10.1542\/peds.2019-3447.","DOI":"10.1542\/peds.2019-3447"},{"issue":"8","key":"395_CR147","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.braindev.2009.09.009","volume":"32","author":"C Iizuka","year":"2010","unstructured":"Iizuka C, Yamashita Y, Nagamitsu S, Yamashita T, Araki Y, Ohya T, et al. Comparison of the strengths and difficulties questionnaire (SDQ) scores between children with high-functioning autism spectrum disorder (HFASD) and attention-deficit\/hyperactivity disorder (AD\/HD). Brain Dev. 2010;32(8):609\u201312. https:\/\/doi.org\/10.1016\/j.braindev.2009.09.009.","journal-title":"Brain Dev"},{"issue":"1","key":"395_CR148","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neulet.2007.02.001","volume":"417","author":"S Jacob","year":"2007","unstructured":"Jacob S, Brune CW, Carter CS, Leventhal BL, Lord C, Cook EH Jr. Association of the oxytocin receptor gene (oxtr) in caucasian children and adolescents with autism. Neurosci Let. 2007;417(1):6\u20139. https:\/\/doi.org\/10.1016\/j.neulet.2007.02.001.","journal-title":"Let"},{"issue":"3","key":"395_CR149","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10803-008-0636-9","volume":"39","author":"LB Jahromi","year":"2009","unstructured":"Jahromi LB, Kasari CL, McCracken JT, Lee LS, Aman MG, McDougle CJ, et al. Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. J\u00a0Autism Development Dis. 2009;39(3):395\u2013404. https:\/\/doi.org\/10.1007\/s10803-008-0636-9. J.","journal-title":"J\u00a0Autism Development Dis."},{"key":"395_CR150","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007992.pub2","author":"S James","year":"2011","unstructured":"James S, Montgomery P, Williams K. Omega\u20113 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2011; https:\/\/doi.org\/10.1002\/14651858.CD007992.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"395_CR151","doi-asserted-by":"crossref","unstructured":"James S, Stevenson SW, Silove N, Williams K. Chelation for autism spectrum disorder (ASD). Coch Data Sys Rev. 2015;11(5):1\u201327, 2015.","DOI":"10.1002\/14651858.CD010766.pub2"},{"issue":"2","key":"395_CR152","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00787-006-0580-1","volume":"16","author":"PS Jensen","year":"2007","unstructured":"Jensen PS, Buitelaar J, Pandina GJ, Binder C, Haas M. Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a\u00a0systematic review of published clinical trials. Eur J Child Adolesc Psychiatry. 2007;16(2):104\u201320.","journal-title":"Eur J Child Adolesc Psychiatry"},{"key":"395_CR153","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005040.pub2","author":"OS Jesner","year":"2007","unstructured":"Jesner OS, Aref-Adib M, Coren E. Risperidone for autism spectrum disorder. Cochrane Database Syst Rev. 2007; https:\/\/doi.org\/10.1002\/14651858.CD005040.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"395_CR154","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/YCO.0000000000000132","volume":"28","author":"NY Ji","year":"2015","unstructured":"Ji NY, Findling RL. An update on pharmacotherapy for autism spectrum disorder in children and adolescents. Curr Opin Psychiatry. 2015;28(2):91\u2013101. https:\/\/doi.org\/10.1097\/YCO.0000000000000132.","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"395_CR155","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1542\/peds.2014-2121","volume":"135","author":"F Jia","year":"2015","unstructured":"Jia F, Wang B, Schan L, Xu Z, Staal WG, Du L. Core symptoms of autism improved after vitamin D supplementation. Pediatrics. 2015;135(1):e196\u2013e8.","journal-title":"Pediatrics"},{"issue":"1","key":"395_CR156","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/acps.12644","volume":"135","author":"K Jobski","year":"2017","unstructured":"Jobski K, Hofer J, Hoffmann F, Bachmann C. Use of psychotropic drugs in patients with autism spectrum disorders: a\u00a0systematic review. Acta Psych Scand. 2017;135(1):8\u201328. https:\/\/doi.org\/10.1111\/acps.12644.","journal-title":"Acta Psych Scand"},{"key":"395_CR157","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.sleep.2012.03.005","volume":"13","author":"CR Johnson","year":"2012","unstructured":"Johnson CR, Turner KS, Foldes EL, Malow BA, Wiggs L. Comparison of sleep questionnaires in the assessment of sleep disturbances in children with autism spectrum disorders. Sleep Med. 2012;13:795\u2013801.","journal-title":"Sleep Med"},{"issue":"2","key":"395_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0172482","volume":"12","author":"RA Jones","year":"2017","unstructured":"Jones RA, Downing K, Rinehart NJJ, Barnett LM, May T, McGillivray JA, et al. Physical activity, sedentary behavior and their correlates in children with autism spectrum disorder: A\u00a0systematic review. PLOS One. 2017;12(2):1\u201323. https:\/\/doi.org\/10.1371\/journal.pone.0172482.","journal-title":"PLOS One"},{"issue":"1","key":"395_CR159","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/acps.12683","volume":"135","author":"G Joshi","year":"2017","unstructured":"Joshi G. Are there lessons to be learned from the prevailing patterns of psychotropic drug use in patients with autism spectrum disorder? Acta Psychiatr Scand. 2017;135(1):5\u20137. https:\/\/doi.org\/10.1111\/acps.12683.","journal-title":"Acta Psychiatr Scand"},{"issue":"10","key":"395_CR160","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1177\/1087054714543368","volume":"21","author":"G Joshi","year":"2017","unstructured":"Joshi G, Faraone SV, Wozniak J, Tarko L, Fried R, Galdo M, et al. Symptom profile of ADHD in youth with high-functioning autism spectrum disorder: a comparative study in psychiatrically referred populations. J\u00a0Atten Disord. 2017;21(10):846\u201355. https:\/\/doi.org\/10.1177\/1087054714543368.","journal-title":"J Atten Disord"},{"issue":"6","key":"395_CR161","doi-asserted-by":"publisher","first-page":"578","DOI":"10.4088\/JCP.12m07392","volume":"74","author":"G Joshi","year":"2013","unstructured":"Joshi G, Biederman J, Petty C, Goldin RL, Furtak SL, Wozniak J. Examining the comorbidity of bipolar disorder and autism spectrum disorders: a\u00a0large controlled analysis of phenotypic and familial correlates in a\u00a0referred population of youth with bipolar I disorder with and without autism spectrum disorders. J\u00a0Clin Psych. 2013;74(6):578\u201386. https:\/\/doi.org\/10.4088\/JCP.12m07392.","journal-title":"J\u00a0Clin Psych."},{"key":"395_CR162","doi-asserted-by":"crossref","unstructured":"Jung S, Sainato DM. Teaching play skills to young children with autism. J\u00a0Intellec Develop Disabil. 2013;38(1):74\u201390. https:\/\/doi.org\/10.3109\/13668250.2012.732220.","DOI":"10.3109\/13668250.2012.732220"},{"issue":"9","key":"395_CR163","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.ridd.2013.06.016","volume":"34","author":"A\u2011K Kantzer","year":"2013","unstructured":"Kantzer A\u2011K, Fernell E, Gillberg C, Miniscalco C. Autism in community pre-schoolers: developmental profiles. Res Develop Disabil. 2013;34(9):2900\u20138. https:\/\/doi.org\/10.1016\/j.ridd.2013.06.016.","journal-title":"Res Develop Disabil"},{"issue":"1","key":"395_CR164","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.pcl.2011.10.005","volume":"59","author":"G Kaplan","year":"2012","unstructured":"Kaplan G, McCracken JT. Psychopharmacology of autism spectrum disorders. Pediat Clin N\u00a0Am. 2012;59(1):175\u201387. https:\/\/doi.org\/10.1016\/j.pcl.2011.10.005.","journal-title":"Am"},{"issue":"3","key":"395_CR165","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10567-012-0119-6","volume":"15","author":"JS Karst","year":"2012","unstructured":"Karst JS, Van\u00a0Hecke AV. Parent and family impact of autism spectrum disorders: a\u00a0review and proposed model for intervention evaluation. Clin Child Fam Psych Rev. 2012;15(3):247\u201377. https:\/\/doi.org\/10.1007\/s10567-012-0119-6.","journal-title":"Psych Rev"},{"issue":"6","key":"395_CR166","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s11920-012-0317-4","volume":"14","author":"C Kasari","year":"2012","unstructured":"Kasari C, Patterson S. Interventions addressing social impairment in autism. Cur Psych Rep. 2012;14(6):713\u201325. https:\/\/doi.org\/10.1007\/s11920-012-0317-4.","journal-title":"Cur Psych Rep"},{"issue":"6","key":"395_CR167","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1542\/peds.2015-1708","volume":"136","author":"KM Kidwell","year":"2015","unstructured":"Kidwell KM, Van\u00a0Dyk TR, Lundahl A, Nelson TD. Stimulant medications and sleep for youth with ADHD: A\u00a0meta-analysis. Pediatrics. 2015;136(6):1144\u201353. https:\/\/doi.org\/10.1542\/peds.2015-1708.","journal-title":"Pediatrics"},{"issue":"6","key":"395_CR168","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","volume":"66","author":"BH King","year":"2009","unstructured":"King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, et al. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior. Arch Gen Psychiatry. 2009;66(6):583\u201390.","journal-title":"Arch Gen Psychiatry"},{"issue":"16","key":"395_CR169","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.2019.11738","volume":"322","author":"BH King","year":"2019","unstructured":"King BH. Fluoxetine and repetitive behaviors in children and adolescents with autism spectrum disorder. JAMA. 2019;322(16):1557\u20138.","journal-title":"JAMA"},{"issue":"8","key":"395_CR170","first-page":"17","volume":"25","author":"E Kirino","year":"2014","unstructured":"Kirino E. Efficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic children. Clin Med Insights Pediatr. 2014;25(8):17\u201330.","journal-title":"Clin Med Insights Pediatr"},{"issue":"6","key":"395_CR171","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00213-013-3403-3","volume":"231","author":"KTE Kleijer","year":"2014","unstructured":"Kleijer KTE, Schmeisser MJ, Krueger DD, Boeckers TM, Scheiffele P, Bourgeron T, et al. Neurobiology of autism gene products: towards pathogenesis and drug targets. Psychopharmacology (Berl.). 2014;231(6):1037\u201362.","journal-title":"Psychopharmacology (Berl.)"},{"key":"395_CR172","doi-asserted-by":"crossref","unstructured":"Knight V, McKissick BR, Saunders A. A\u00a0review of technology-based interventions to teach academic skills to students with autism spectrum disorder. J\u00a0Autism Develop Disord. 2013. https:\/\/doi.org\/10.1007\/s10803-013-1814-y.","DOI":"10.1007\/s10803-013-1814-y"},{"issue":"3","key":"395_CR173","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4088\/JCP.v67n0311","volume":"67","author":"A Kolevzon","year":"2006","unstructured":"Kolevzon A, Mathewson KA, Hollander E. Selective serotonin reuptake inhibitors in autism: a\u00a0review of efficacy and tolerability. J\u00a0Clin Psychiatry. 2006;67(3):407\u201314.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"395_CR174","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s11940-012-0199-0","volume":"14","author":"S Kotagal","year":"2012","unstructured":"Kotagal S. Treatment of dyssomnias and parasomnias in childhood. Curr Treat Options Neurol. 2012;14(6):630\u201349.","journal-title":"Curr Treat Options Neurol"},{"issue":"4","key":"395_CR175","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.pediatrneurol.2012.05.007","volume":"47","author":"S Kotagal","year":"2012","unstructured":"Kotagal S, Broomall A. Sleep in children with autism spectrum disorder. Pediat Neurol. 2012;47(4):242\u201351. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2012.05.007.","journal-title":"Neurol"},{"issue":"4","key":"395_CR176","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41386-018-0258-7","volume":"44","author":"JA Kruppa","year":"2019","unstructured":"Kruppa JA, Gossen A, Oberwelland Wei\u00df E, Kohls G, Gro\u00dfheinrich N, Cholemkery H, et al. Neural modulation of social reinforcement learning by intranasal oxytocin in male adults with high-functioning autism spectrum disorder: a\u00a0randomized trial. Neuropsychopharmacology. 2019;44(4):749\u201356. https:\/\/doi.org\/10.1038\/s41386-018-0258-7.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"395_CR177","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/eb-2012-100985","volume":"16","author":"LEA Review","year":"2013","unstructured":"Laugeson EA. Review: social skills groups may improve social competence in children and adolescents with autism spectrum disorder. Evidence-Based Mental Health. 2013;16(1):11. https:\/\/doi.org\/10.1136\/eb-2012-100985.","journal-title":"Evidence-Based Mental Health"},{"issue":"1","key":"395_CR178","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.pcl.2011.10.006","volume":"59","author":"LA LeBlanc","year":"2012","unstructured":"LeBlanc LA, Gillis JM. Behavioral interventions for children with autism spectrum disorders. Ped Clin N\u00a0Am. 2012;59(1):147\u201364. https:\/\/doi.org\/10.1016\/j.pcl.2011.10.006.","journal-title":"Am"},{"issue":"6","key":"395_CR179","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1089\/cap.2006.16.737","volume":"16","author":"DO Lee","year":"2006","unstructured":"Lee DO, Ousley OY. Attention-deficit hyperactivity disorder symptoms in a\u00a0clinic sample of children and adolescents with pervasive developmental disorders. J\u00a0Child Adoles Psychopharmacol. 2006;16(6):737\u201346. https:\/\/doi.org\/10.1089\/cap.2006.16.737.","journal-title":"Psychopharmacol"},{"issue":"1","key":"395_CR180","doi-asserted-by":"publisher","first-page":"19","DOI":"10.9758\/cpn.2014.12.1.19","volume":"12","author":"YJ Lee","year":"2014","unstructured":"Lee YJ, Oh SH, Park C, Hong M, Lee AR, Yoo HJ, et al. Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder. Clin Psychopharmacol Neurosci. 2014;12(1):19\u201330. https:\/\/doi.org\/10.9758\/cpn.2014.12.1.19.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"395_CR181","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fnhum.2014.00268","volume":"8","author":"Y Leitner","year":"2014","unstructured":"Leitner Y. The co-occurrence of autism and attention deficit hyperactivity disorder in children \u2013 What do we know? Front Hum Neurosci. 2014;8:268. https:\/\/doi.org\/10.3389\/fnhum.2014.00268.","journal-title":"Front Hum Neurosci"},{"issue":"2","key":"395_CR182","first-page":"177","volume":"40","author":"MD Lerner","year":"2012","unstructured":"Lerner MD, Haque OS, Northrup EC, Lawer L, Bursztajn HJ. Emerging perspectives on adolescents and young adults with high-functioning autism spectrum disorders, violence, and criminal law. J\u00a0Am Acad Psych Law. 2012;40(2):177\u201390.","journal-title":"J\u00a0Am Acad Psych Law."},{"issue":"3","key":"395_CR183","first-page":"307","volume":"14","author":"MD Lerner","year":"2012","unstructured":"Lerner MD, White SW, McPartland JC. Mechanisms of change in psychosocial interventions for autism spectrum disorders. Dialog Clin Neurosci. 2012;14(3):307\u201318.","journal-title":"Neurosci."},{"issue":"5","key":"395_CR184","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3171\/2010.3.PEDS09153","volume":"5","author":"ML Levy","year":"2010","unstructured":"Levy ML, Levy KM, Hoff D, Amar AP, Park MS, Conklin JM, et al. Vagus nerve stimulation therapy in patients with autism spectrum disorder and intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry. J\u00a0Neurosurg Pediatr. 2010;5(5):595\u2013602.","journal-title":"J Neurosurg Pediatr"},{"key":"395_CR185","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/00004703-200312000-00003","volume":"24","author":"S Levy","year":"2003","unstructured":"Levy S. Complementary and alternative medicine among children recently diagnosed with Autistic Spectrum Disorder. J\u00a0Dev Behav Pediatr. 2003;24:418\u201323.","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"395_CR186","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.chc.2014.09.004","volume":"24","author":"SE Levy","year":"2015","unstructured":"Levy SE, Hyman SL. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatry. 2015;24(1):117\u201343.","journal-title":"Child Adolesc Psychiatry"},{"issue":"7","key":"395_CR187","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10803-006-0123-0","volume":"36","author":"OT Leyfer","year":"2006","unstructured":"Leyfer OT, Folstein SE, Bacalman S, Davis NO, Dinh E, Morgan J, et al. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J\u00a0Autism Dev Disord. 2006;36(7):849\u201361. https:\/\/doi.org\/10.1007\/s10803-006-0123-0.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"395_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11689-017-9207-8","volume":"9","author":"A Ligsay","year":"2017","unstructured":"Ligsay A, Van\u00a0Dijck A, Nguyen DV, Lozano R, Chen Y, Bickel ES, et al. A\u00a0randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome. J\u00a0Neurodevelop Disord. 2017;9(1:26):1\u201313. https:\/\/doi.org\/10.1186\/s11689-017-9207-8.","journal-title":"Neurodevelop"},{"key":"395_CR189","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10578-006-0028-3","volume":"37","author":"X Liu","year":"2006","unstructured":"Liu X, Hubbard JA, Fabes RA, Adam JB. Sleep disturbances and correlates of children with autism spectrum disorders. Child Psychiatry Hum Dev. 2006;37:179\u201391.","journal-title":"Child Psychiatry Hum Dev"},{"issue":"5","key":"395_CR190","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/cn500077p","volume":"18","author":"Z Liu","year":"2014","unstructured":"Liu Z, Smith CB. Lithium: a\u00a0promising treatment for fragile X syndrome. ACS Chem Neurosci. 2014;18(5):477\u201383.","journal-title":"ACS Chem Neurosci"},{"key":"395_CR191","doi-asserted-by":"publisher","first-page":"870391","DOI":"10.1155\/2012\/870391","volume":"2012","author":"N Lofthouse","year":"2012","unstructured":"Lofthouse N, Hendren R, Hurt E, Arnold LE, Butter E. A\u00a0review of complementary and alternative treatments for autism spectrum disorders. Autism Res Treat. 2012;2012:870391. https:\/\/doi.org\/10.1155\/2012\/870391.","journal-title":"Autism Res Treat"},{"key":"395_CR192","volume-title":"Educating children with autism","author":"C Lord","year":"2001","unstructured":"Lord C, McGee JP. Educating children with autism. Washington, DC: National Academic Press; 2001."},{"issue":"8","key":"395_CR193","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s10620-012-2286-1","volume":"57","author":"P Louis","year":"2012","unstructured":"Louis P. Does the human gut microbiota contribute to the etiology of autism spectrum disorders? Dig Dis Sci. 2012;57(8):1987\u20139. https:\/\/doi.org\/10.1007\/s10620-012-2286-1.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"395_CR194","first-page":"1","volume":"3","author":"F Mahdi","year":"2019","unstructured":"Mahdi F, Setiawati Y. Occupational therapy for children with attention deficit hyperactivity disorder: a literature review. J\u00a0Child Adolesc Psychiatry. 2019;3(1):1\u20133.","journal-title":"J Child Adolesc Psychiatry"},{"issue":"6","key":"395_CR195","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1089\/cap.2006.0126","volume":"17","author":"RP Malone","year":"2007","unstructured":"Malone RP, Delaney MA, Hyman SB, Cater JR. Ziprasidone in adolescents with autism: an open-label pilot study. J\u00a0Child Adolesc Psychopharmacol. 2007;17(6):779\u201390.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"395_CR196","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1089\/cap.2013.0143","volume":"24","author":"A Maloney","year":"2014","unstructured":"Maloney A, Mick EO, Frazier J. Aripiprazole decreases irritability in 12 out of 14 youth with autism spectrum disorders. J\u00a0Child Adolesc Psychopharmacol. 2014;24(6):357\u20139.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"Suppl\u00a02","key":"395_CR197","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1542\/peds.2012-0900I","volume":"130","author":"BA Malow","year":"2012","unstructured":"Malow BA, Byars K, Johnson K, Weiss S, Bernal P, Goldman SE, et al. A\u00a0practice pathway for the identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders. Pediatrics. 2012;130(Suppl\u00a02):S106\u201324. https:\/\/doi.org\/10.1542\/peds.2012-0900I.","journal-title":"Pediatrics"},{"key":"395_CR198","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez K, Mart\u00ednez-Garc\u00eda M, Marcos-Vidal L, Janssen J, Castellanos FX, Pretus C, et al. Sensory-to-cognitive systems integration is associated with clinical severity in autism spectrum disorder. J\u00a0Am Acad Child Adoles Psych. 2019; electronic preprint:1\u201311, 2019. https:\/\/doi.org\/10.1016\/j.jaac.2019.05.033.","DOI":"10.1016\/j.jaac.2019.05.033"},{"key":"395_CR199","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2147\/ndt.s65735","volume":"11","author":"J Martinez-Raga","year":"2015","unstructured":"Martinez-Raga J, Knecht C, de\u00a0Alvaro R. Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder. Neuropsych Dis Treat. 2015;11:1359\u201370. https:\/\/doi.org\/10.2147\/ndt.s65735.","journal-title":"Neuropsych Dis Treat"},{"issue":"2","key":"395_CR200","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40272-015-0119-3","volume":"17","author":"G Masi","year":"2015","unstructured":"Masi G, Milone A, Veltri S, Iuliano R, Pfanner C, Pisano S. Use of quetiapine in children and adolescents. Paediatr Drugs. 2015;17(2):125\u201340.","journal-title":"Paediatr Drugs"},{"issue":"5","key":"395_CR201","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.ridd.2014.02.012","volume":"35","author":"JL Matson","year":"2014","unstructured":"Matson JL, Cervantes PE. Commonly studied comorbid psychopathologies among persons with autism spectrum disorder. Res Dev Disabil. 2014;35(5):952\u201362. https:\/\/doi.org\/10.1016\/j.ridd.2014.02.012.","journal-title":"Res Dev Disabil"},{"key":"395_CR202","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11571-008-9051-3","volume":"2","author":"H Matsuura","year":"2008","unstructured":"Matsuura H, Tateno K, Aou S. Dynamical properties of the two-process model for sleep-wake cycles in infantile autism. Cogn Neurodyn. 2008;2:221\u20138.","journal-title":"Cogn Neurodyn"},{"issue":"10","key":"395_CR203","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/bies.201400075","volume":"36","author":"EA Mayer","year":"2014","unstructured":"Mayer EA, Padua D, Tillisch K. Altered brain-gut axis in autism: comorbidity or causative mechanisms? Bioassays. 2014;36(10):933\u20139.","journal-title":"Bioassays"},{"issue":"4","key":"395_CR204","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/nu8040236","volume":"8","author":"H Mazahery","year":"2016","unstructured":"Mazahery H, Camargo\u00a0Jr CA , Conlon C, Beck KL, Kruger MC, von Hurst PR. Vitamin D and Autism Spectrum Disorder: A Literature Review. Nutrients. 2016;8(4):236. https:\/\/doi.org\/10.3390\/nu8040236.","journal-title":"Nutrients"},{"issue":"5","key":"395_CR205","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s10803-019-03894-5","volume":"49","author":"MO Mazurek","year":"2019","unstructured":"Mazurek MO, Dovgan K, Neumeyer AM, Malow BA. Course and predictors of sleep and co-occurring problems in children with autism spectrum disorder. J\u00a0Autism Dev Disord. 2019;49(5):2101\u201315. https:\/\/doi.org\/10.1007\/s10803-019-03894-5.","journal-title":"J Autism Dev Disord"},{"issue":"3","key":"395_CR206","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/tpj.2013.23","volume":"14","author":"JT McCracken","year":"2014","unstructured":"McCracken JT, Badashova KK, Posey DJ, Aman MG, Scahill L, Tierney E, et al. Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders. Pharmacogenomics. 2014;14(3):295\u2013302.","journal-title":"Pharmacogenomics"},{"key":"395_CR207","doi-asserted-by":"crossref","unstructured":"McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, et al., and for Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioral problems. New Eng J\u00a0Med. 2002;347(5):314\u201321. https:\/\/doi.org\/10.1056\/NEJMoa013171.","DOI":"10.1056\/NEJMoa013171"},{"issue":"1","key":"395_CR208","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S1056-4993(18)30142-1","volume":"9","author":"CJ McDougle","year":"2000","unstructured":"McDougle CJ, Scahill L, McCracken JT, Aman MG, Tierney E, Arnold LE, et al. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. Child Adolesc Psychiatr Clin N Am. 2000;9(1):201\u201324.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"4","key":"395_CR209","first-page":"359","volume":"97","author":"JJ McEachin","year":"1993","unstructured":"McEachin JJ, Smith T, Lovaas OI. Long-term outcome for children with autism who received early intensive behavioral treatment. Am J Ment Retard. 1993;97(4):359\u201372.","journal-title":"Am J Ment Retard"},{"issue":"5","key":"395_CR210","doi-asserted-by":"publisher","first-page":"e1312","DOI":"10.1542\/peds.2011-0427","volume":"127","author":"ML McPheeters","year":"2011","unstructured":"McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, et al. A\u00a0systematic review of medical treatments for children with autism spectrum disorders. Pediatrics. 2011;127(5):e1312\u2013e21.","journal-title":"Pediatrics"},{"key":"395_CR211","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-306-48647-0","volume-title":"The TEACCH approach to autism spectrum disorders. Issues in clinical child psychology","author":"GB Mesibov","year":"2004","unstructured":"Mesibov GB, Shea V, Schopler E. The TEACCH approach to autism spectrum disorders. Issues in clinical child psychology. New York: Springer; 2004."},{"key":"395_CR212","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2014.00906","author":"JA Micoulaud-Franchi","year":"2014","unstructured":"Micoulaud-Franchi JA, Geoffroy PA, Fond G, Lopez R, Bioulac S, Philip P. EEG neurofeedback treatments in children with ADHD: An updated meta-analysis of randomized controlled trials. Front Hum Neurosci. 2014; https:\/\/doi.org\/10.3389\/fnhum.2014.00906.","journal-title":"Front Hum Neurosci"},{"issue":"4","key":"395_CR213","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.chc.2014.05.007","volume":"23","author":"AY Mikami","year":"2014","unstructured":"Mikami AY, Jia M, Na JJ. Social skills training. Child Adoles Psych Clin N\u00a0Am. 2014;23(4):775\u201388. https:\/\/doi.org\/10.1016\/j.chc.2014.05.007.","journal-title":"Am"},{"key":"395_CR214","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13229-015-0062-8","volume":"7","author":"NF Minshawi","year":"2016","unstructured":"Minshawi NF, Wink LK, Shaffer R, Plawecki MH, Posey DJ, Liu H, et al. A\u00a0randomized, placebo-controlled trial of d\u2011cycloserine for the enhancement of social skills training in autism spectrum disorders. Mol Autism. 2016;7:2. https:\/\/doi.org\/10.1186\/s13229-015-0062-8.","journal-title":"Mol Autism"},{"key":"395_CR215","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1038\/npp.2015.35","volume":"40","author":"ME Modi","year":"2015","unstructured":"Modi ME, Inoue K, Barrett CE, Kittelberger KA, Smith DG, Landgraf R, et al. Melanocortin receptor agonists facilitate oxytocin-dependent partner preference formation in the prairie vole. Neuropsychopharmacology. 2015;40:1856\u201365.","journal-title":"Neuropsychopharmacology"},{"key":"395_CR216","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apha.2014.10.008","volume":"72","author":"H M\u00f6hler","year":"2015","unstructured":"M\u00f6hler H. The legacy of the benzodiazepine receptor: from flumazenil to enhancing cognition in Down syndrome and social interaction in autism. Adv Pharmacol. 2015;72:1\u201336. https:\/\/doi.org\/10.1016\/bs.apha.2014.10.008.","journal-title":"Adv Pharmacol"},{"key":"395_CR217","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1749-6632.2012.06465.x","volume":"1252","author":"I Molnar-Szakacs","year":"2012","unstructured":"Molnar-Szakacs I, Heaton P. Music: a\u00a0unique window into the world of autism. Ann New York Acad Sci. 2012;1252:318\u201324. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06465.x.","journal-title":"Ann New York Acad Sci"},{"issue":"4","key":"395_CR218","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2174\/15748847113086660070","volume":"9","author":"M Molteni","year":"2014","unstructured":"Molteni M, Nobile M, Cattaneo D, Radice S, Clementi E. Potential benefits and limits of psychopharmacological therapies in pervasive developmental disorders. CCP. 2014;9(4):365\u201376.","journal-title":"CCP"},{"issue":"3","key":"395_CR219","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.eurpsy.2010.10.005","volume":"26","author":"A Montoya","year":"2011","unstructured":"Montoya A, Colom F, Ferrin M. Is psychoeducation for parents and teachers of children and adolescents with ADHD efficacious? A systematic literature review. Eur psychiatr. 2011;26(3):166\u201375. https:\/\/doi.org\/10.1016\/j.eurpsy.2010.10.005.","journal-title":"Eur psychiatr"},{"issue":"2","key":"395_CR220","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40272-013-0050-4","volume":"16","author":"WN Moyal","year":"2014","unstructured":"Moyal WN, Lord C, Walkup JT. Quality of life in children and adolescents with autism spectrum disorders: what is known about the effects of pharmacotherapy? Paediatr Drugs. 2014;16(2):123\u20138.","journal-title":"Paediatr Drugs"},{"key":"395_CR221","doi-asserted-by":"crossref","unstructured":"Myers SM, Plauch\u00e9 Johnson C, and the Council on Children With Disabilities. Management of children with autism spectrum disorders. Pediatrics. 2007;120(5):1162\u201382. https:\/\/doi.org\/10.1542\/peds.2007-2362.","DOI":"10.1542\/peds.2007-2362"},{"issue":"6","key":"395_CR222","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2217\/npy.11.62","volume":"1","author":"J Nadeau","year":"2011","unstructured":"Nadeau J, Sulkowski ML, Ung D, Wood JJ, Lewin AB, Murphy TK, et al. Treatment of comorbid anxiety and autism spectrum disorders. Neuropsychiatry (london). 2011;1(6):567\u201378.","journal-title":"Neuropsychiatry (london)"},{"issue":"2","key":"395_CR223","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00004583-200102000-00008","volume":"40","author":"JH Newcorn","year":"2001","unstructured":"Newcorn JH, Halperin JM, Jensen PS, Abikoff HB, Arnold LE, Cantwell DP, et al. Symptom profiles in children with ADHD: Effects of comorbidity and gender. J\u00a0Am Acad Child Adoles Psych. 2001;40(2):137\u201346.","journal-title":"J\u00a0Am Acad Child Adoles Psych."},{"issue":"1","key":"395_CR224","first-page":"PCC.10I0138","volume":"13","author":"H Niederhofer","year":"2011","unstructured":"Niederhofer H. Efficacy of Duloxetine and Agomelatine does not exceed that of other antidepressants in patients with autistic disorder: preliminary results in 3 patients. Prim Care Companion Cns Disord. 2011;13(1):PCC.10I0138.","journal-title":"Prim Care Companion Cns Disord"},{"issue":"7","key":"395_CR225","first-page":"675","volume":"49","author":"JS Nijmeijer","year":"2010","unstructured":"Nijmeijer JS, Arias-V\u00e1squez A, Rommelse NNJ, Altink ME, Anney RJL, Asherson P, et al. Identifying loci for the overlap between attention-deficit\/hyperactivity disorder and autism spectrum disorder using a\u00a0genome-wide QTL linkage approach. J\u00a0Am Acad Child Adoles Psych. 2010;49(7):675\u201385.","journal-title":"J\u00a0Am Acad Child Adoles Psych."},{"issue":"1","key":"395_CR226","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s40617-018-00312-7","volume":"12","author":"MN Novack","year":"2018","unstructured":"Novack MN, Hong E, Dixon DR, Granpeesheh D. An evaluation of a\u00a0mobile application designed to teach receptive language skills to children with autism spectrum disorder. Behav Analysis Practice. 2018;12(1):66\u201377. https:\/\/doi.org\/10.1007\/s40617-018-00312-7.","journal-title":"Behav Analysis Practice"},{"issue":"6","key":"395_CR227","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1006\/ebeh.2001.0285","volume":"2","author":"LM Ojemann","year":"2001","unstructured":"Ojemann LM, Ojemann GA, Dodrill CB, Crawford CA, Holmes MD, Dudley DL. Language disturbances as side effects of topiramate and zonisamide therapy. Epilepsy Behav. 2001;2(6):579\u201384. https:\/\/doi.org\/10.1006\/ebeh.2001.0285.","journal-title":"Epilepsy Behav"},{"issue":"1","key":"395_CR228","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-0042-109400","volume":"50","author":"YP Ooi","year":"2017","unstructured":"Ooi YP, Weng S-J, Kossowsky J, Gerger H, Sung M. Oxytocin and autism spectrum disorders: a\u00a0systematic review and meta-analysis of randomized controlled trials. Pharmacopsychiatry. 2017;50(1):5\u201313. https:\/\/doi.org\/10.1055\/s-0042-109400.","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"395_CR229","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/DBP.0000000000000037","volume":"35","author":"AJ Orinstein","year":"2014","unstructured":"Orinstein AJ, Helt M, Troyb E, Tyson KE, Barton ML, Eigsti I-M, et al. Intervention history of children and adolescents with high- functioning autism and optimal outcomes. J\u00a0Dev Behav Pediatr. 2014;35(4):247\u201356. https:\/\/doi.org\/10.1097\/DBP.0000000000000037.","journal-title":"J Dev Behav Pediatr"},{"issue":"7","key":"395_CR230","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1093\/brain\/awz126","volume":"142","author":"K Owada","year":"2019","unstructured":"Owada K, Okada T, Munesue T, Kuroda M, Fujioka T, Uno Y, et al. Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism. Brain. 2019;142(7):2127\u201336. https:\/\/doi.org\/10.1093\/brain\/awz126.","journal-title":"Brain"},{"issue":"6","key":"395_CR231","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1542\/peds.2008-3782","volume":"124","author":"R Owen","year":"2009","unstructured":"Owen R, Linmarie Sikich RNM, Corey-Lisle P, Manos G, McQuade RD, Carson WH, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009;124(6):1533\u201340. https:\/\/doi.org\/10.1542\/peds.2008-3782.","journal-title":"Pediatrics"},{"issue":"4","key":"395_CR232","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/01.chi.0000153229.80215.a0","volume":"44","author":"T Owley","year":"2005","unstructured":"Owley T, Walton L, Salt J, Guter S, Winnega M, Leventhal BL, et al. An open-label trial of excitalopram in pervasive developmental disorders. J\u00a0Am Acad Child Adolesc Psychiatry. 2005;44(4):343\u20138.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"395_CR233","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/cap.2006.16.517","volume":"16","author":"T Owley","year":"2006","unstructured":"Owley T, Salt J, Guter S, Grieve A, Walton L, Ayuyao N, et al. A\u00a0prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders. J\u00a0Child Adolesc Psychopharmacol. 2006;16(5):517\u201324.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"3","key":"395_CR234","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4088\/PCC.v03n0303","volume":"3","author":"JF Pagel","year":"2001","unstructured":"Pagel JF, Parnes BL. Medications for the treatment of sleep disorders: an overview. Prim Care Companion J Clin Psychiatry. 2001;3(3):118\u201325.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"491","key":"395_CR235","doi-asserted-by":"publisher","first-page":"eaau7356","DOI":"10.1126\/scitranslmed.aau7356","volume":"11","author":"KJ Parker","year":"2019","unstructured":"Parker KJ, Oztan O, Libove RA, Mohsin DS, Karhson N, Sumiyoshi RD, et al. A\u00a0randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism. Sci Transl Med. 2019;11(491):eaau7356. https:\/\/doi.org\/10.1126\/scitranslmed.aau7356.","journal-title":"Sci Transl Med"},{"issue":"4","key":"395_CR236","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/aur.2059","volume":"12","author":"S Patra","year":"2019","unstructured":"Patra S, Nebhinani N, Viswanathan A, Kirubakaran R. Atomoxetine for attention deficit hyperactivity disorder in children and adolescents with autism: A\u00a0systematic review and meta-analysis. Autism Res. 2019;12(4):542\u201352. https:\/\/doi.org\/10.1002\/aur.2059.","journal-title":"Autism Res."},{"issue":"6","key":"395_CR237","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1096\/fj.13-246546","volume":"28","author":"RP Patrick","year":"2014","unstructured":"Patrick RP, Ames BN. Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB\u00a0J. 2014;28(6):2398\u2013413.","journal-title":"FASEB J"},{"issue":"5","key":"395_CR238","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/cap.2012.0096","volume":"23","author":"DA Pearson","year":"2013","unstructured":"Pearson DA, Santos CW, Aman MG, Arnold LE, Casat CD, Mansour R, et al. Effects of extended release methylphenidate treatment on ratings of attention-deficit\/hyperactivity disorder (adhd) and associated behavior in children with autism spectrum disorders and ADHD symptoms. J\u00a0Child Adoles Psychopharmacol. 2013;23(5):337\u201351. https:\/\/doi.org\/10.1089\/cap.2012.0096.","journal-title":"J\u00a0Child Adoles Psychopharmacol."},{"issue":"1","key":"395_CR239","doi-asserted-by":"publisher","first-page":"e0169277","DOI":"10.1371\/journal.pone.0169277","volume":"12","author":"LM Pelsser","year":"2017","unstructured":"Pelsser LM, Frankena K, Toorman J, Rodrigues\u00a0Pereira\u00a0R. Diet and ADHD, reviewing the evidence: A\u00a0systematic review of meta-analyses of double-blind placebo-controlled trials evaluating the efficacy of diet interventions on the behavior of children with ADHD. PLOS ONE. 2017;12(1):e0169277. https:\/\/doi.org\/10.1371\/journal.pone.0169277.","journal-title":"PLOS ONE"},{"issue":"4","key":"395_CR240","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5607\/en.2015.24.4.301","volume":"24","author":"O Penagarikano","year":"2015","unstructured":"Penagarikano O. New therapeutic options for autism spectrum disorder: Experimental evidences. Exp Neurobiol. 2015;24(4):301\u201311. https:\/\/doi.org\/10.5607\/en.2015.24.4.301.","journal-title":"Exp Neurobiol"},{"issue":"2","key":"395_CR241","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/HRP.0000000000000030","volume":"22","author":"LC Politte","year":"2014","unstructured":"Politte LC, Henry CA, McDougle CJ. Psychopharmacological interventions in autism spectrum disorder. Harv Rev Psychiatry. 2014;22(2):76\u201392. https:\/\/doi.org\/10.1097\/HRP.0000000000000030.","journal-title":"Harv Rev Psychiatry"},{"issue":"2","key":"395_CR242","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00004583-199902000-00004","volume":"38","author":"DI Posey","year":"1999","unstructured":"Posey DI, Litwiller M, Koburn A, McDougle CJ. Paroxetine in autism. J\u00a0Am Acad Child Adolesc Psychiatry. 1999;38(2):111\u20132.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"395_CR243","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/10445460152595586","volume":"11","author":"DJ Posey","year":"2001","unstructured":"Posey DJ, Guenin KD, Kohn AE, Swiezy NB, McDougle CJ. A\u00a0naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders. J\u00a0Child Adolesc Psychopharmacol. 2001;11:267\u201377.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"395_CR244","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1089\/cap.2006.16.599","volume":"16","author":"DJ Posey","year":"2006","unstructured":"Posey DJ, Wiegand RE, Wilkerson J, Maynard M, Stigler KA, McDougle CJJ. Open-label atomoxetine for attention-deficit\/hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. J\u00a0Child Adolesc Psychopharmacol. 2006;16(5):599\u2013610.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"395_CR245","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1024\/1422-4917\/a000099","volume":"39","author":"L Poustka","year":"2011","unstructured":"Poustka L, Bender F, Bock M, B\u00f6lte S, M\u00f6hler E, Banaschewski T, et al. Temperament und soziale Reaktivi\u00e4t bei Autismus-Spektrum-St\u00f6rungen und ADHS [Personality and social responsiveness in autism spectrum disorders and attention deficit\/hyperactivity disorder]. Z\u00a0Kinder Jugendpsychiatr Psychother. 2011;39:133\u201341. https:\/\/doi.org\/10.1024\/1422-4917\/a000099.","journal-title":"Z Kinder Jugendpsychiatr Psychother"},{"issue":"1","key":"395_CR246","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3233\/RNN-139010","volume":"32","author":"L Poustka","year":"2014","unstructured":"Poustka L, Brandeis D, Hohmann M, B\u00f6lte S, Banaschewski T. Neurobiologically based interventions for autism spectrum disorders - rationale neurobiology based interventions for autism spectrum disorders - rationale and new directions. RNN. 2014;32(1):197\u2013212.","journal-title":"RNN"},{"key":"395_CR247","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.lfs.2019.03.053","volume":"224","author":"M Premoli","year":"2019","unstructured":"Premoli M, Aria F, Bonini SA, Maccarinelli G, Gianoncelli A, Pina SD, et al. Cannabidiol: recent advances and new insights for neuropsychiatric disorders treatment. Life. 2019;224:120\u20137.","journal-title":"Life"},{"issue":"2","key":"395_CR248","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1089\/cap.2013.0040","volume":"24","author":"A Preti","year":"2014","unstructured":"Preti A, Melis M, Siddi S, Vellante M, Doneddu G, Fadda R. Oxytocin and autism: a\u00a0systematic review of randomized controlled trials. J\u00a0Child Adolesc Psychopharmacol. 2014;24(2):54\u201368.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"395_CR249","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.spen.2010.10.008","volume":"17","author":"T Rajapakse","year":"2010","unstructured":"Rajapakse T, Pringsheim T. Pharmacotherapeutics of Tourette syndrome and stereotypies in autism. Semin Pediatr Neurol. 2010;17(4):254\u201360.","journal-title":"Semin Pediatr Neurol"},{"issue":"2","key":"395_CR250","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/17518423.2011.651655","volume":"15","author":"S Ramdoss","year":"2012","unstructured":"Ramdoss S, Machalicek W, Rispoli M, Mulloy A, Lang R, O\u2019Reilly M. Computer-based interventions to improve social and emotional skills in individuals with autism spectrum disorders: a\u00a0systematic review. Dev Neurorehabil. 2012;15(2):119\u201335. https:\/\/doi.org\/10.3109\/17518423.2011.651655.","journal-title":"Dev Neurorehabil"},{"issue":"3","key":"395_CR251","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/1362361312470494","volume":"18","author":"PA Rao","year":"2013","unstructured":"Rao PA, Landa RJ. Association between severity of behavioral phenotype and comorbid attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders. Autism. 2013;18(3):272\u201380. https:\/\/doi.org\/10.1177\/1362361312470494.","journal-title":"Autism"},{"key":"395_CR252","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.2147\/ndt.s178839","volume":"14","author":"B Razoki","year":"2018","unstructured":"Razoki B. Neurofeedback versus psychostimulants in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder: a\u00a0systematic review. Neuropsych Dis Treat. 2018;14:2905\u201313. https:\/\/doi.org\/10.2147\/ndt.s178839.","journal-title":"Neuropsych Dis Treat"},{"issue":"16","key":"395_CR253","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/jama.2019.14685","volume":"322","author":"DS Reddihough","year":"2019","unstructured":"Reddihough DS, Marraffa C, Mouti A, O\u2019Sullivan M, Lee KJ, Orsini F, et al. Effect of fluoxetine on obsessive-compulsive behaviors in children and adolescents with autism spectrum disorders. A randomized clinical trial. JAMA. 2019;322(16):1561\u20139.","journal-title":"JAMA"},{"issue":"CD009260","key":"395_CR254","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD009260.pub2","volume":"10","author":"B Reichow","year":"2012","unstructured":"Reichow B, Barton EE, Boyd BA, Hume K. Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD). Cochrane Database Sys Rev. 2012;10(CD009260):1\u201363. https:\/\/doi.org\/10.1002\/14651858.CD009260.pub2.","journal-title":"Cochrane Database Sys Rev"},{"key":"395_CR255","doi-asserted-by":"crossref","unstructured":"Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. A\u00a0randomized controlled crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psych. 2005;62:1266\u20131274.","DOI":"10.1001\/archpsyc.62.11.1266"},{"key":"395_CR256","doi-asserted-by":"crossref","unstructured":"Reynolds AM, Soke GN, Sabourin KR, Hepburn S, Katz T, Wiggins LD, et al. Sleep problems in 2\u2011 to 5\u2011year-olds with autism spectrum disorder and other developmental delays. Pediatrics. 2019;14(3):pii:e20180492. https:\/\/doi.org\/10.1542\/peds.2018-0492.","DOI":"10.1542\/peds.2018-0492"},{"issue":"7","key":"395_CR257","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.pnpbp.2010.07.005","volume":"34","author":"V Rezaei","year":"2010","unstructured":"Rezaei V, Mohammadi MR, Ghanizadeh A, Sahraian A, Tabrizi M, Rezzadeh SA, et al. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(7):1269\u201372.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"395_CR258","doi-asserted-by":"publisher","first-page":"237","DOI":"10.21037\/tp.2017.09.14","volume":"6","author":"E Richardson","year":"2017","unstructured":"Richardson E, Seibert T, Uli NK. Growth perturbations from stimulant medications and inhaled corticosteroids. Transl Pediatr. 2017;6(4):237\u201347. https:\/\/doi.org\/10.21037\/tp.2017.09.14.","journal-title":"Transl Pediatr"},{"issue":"3","key":"395_CR259","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s12671-017-0815-x","volume":"9","author":"A Ridderinkhof","year":"2018","unstructured":"Ridderinkhof A, de Bruin EI, Blom R, B\u00f6gels SM. Mindfulness-based program for children with autism spectrum disorder and their parents: Direct and long-term improvements. Mindfulness. 2018;9(3):773\u201391. https:\/\/doi.org\/10.1007\/s12671-017-0815-x.","journal-title":"Mindfulness"},{"issue":"8","key":"395_CR260","first-page":"1081","volume":"21","author":"JM Ringman","year":"2000","unstructured":"Ringman JM, Jankovic J. Occurrence of tics in Asperger\u2019s syndrome and autistic disorder. J\u00a0Child Neurol. 2000;21(8):1081\u2013109.","journal-title":"J Child Neurol"},{"issue":"3","key":"395_CR261","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11065-012-9212-3","volume":"22","author":"SJ Robinson","year":"2012","unstructured":"Robinson SJ. Childhood epilepsy and autism spectrum disorders: psychiatric problems, phenotypic expression, and anticonvulsants. Neuropsychol Rev. 2012;22(3):271\u20139. https:\/\/doi.org\/10.1007\/s11065-012-9212-3.","journal-title":"Neuropsychol Rev"},{"issue":"4","key":"395_CR262","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1024\/1422-4917\/a000176","volume":"40","author":"V Roessner","year":"2012","unstructured":"Roessner V, Schoenefeld K, Buse J, Wanderer S, Rothenberger A. Therapie der Tic-St\u00f6rungen [Therapy of tic disorders]. Z\u00a0Kinder Jugendpsychiatr. 2012;40(4):217\u201337.","journal-title":"Z Kinder Jugendpsychiatr"},{"issue":"1","key":"395_CR263","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/15374410701817808","volume":"37","author":"SJ Rogers","year":"2008","unstructured":"Rogers SJ, Vismara LA. Evidence-based comprehensive treatments for early autism. J\u00a0Clin Child Adolesc Psychol. 2008;37(1):8\u201338.","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"6","key":"395_CR264","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10802-009-9312-6","volume":"37","author":"NNJ Rommelse","year":"2009","unstructured":"Rommelse NNJ, Altink ME, Fliers EA, Martin NC, Buschgens CJM, Hartman CA, et al. Comorbid problems in ADHD: degree of association, shared endophenotypes, and formation of distinct subtypes. implications for a\u00a0future DSM. J\u00a0Abnorm Child Psych. 2009;37(6):793\u2013804. https:\/\/doi.org\/10.1007\/s10802-009-9312-6.","journal-title":"future DSM. J\u00a0Abnorm Child Psych."},{"issue":"5","key":"395_CR265","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1469-7610.2007.01857.x","volume":"49","author":"A Ronald","year":"2008","unstructured":"Ronald A, Simonoff E, Kuntsi J, Asherson P, Plomin R. Evidence for overlapping genetic influences on autistic and ADHD behaviours in a\u00a0community twin sample. J\u00a0Child Psychol Psychiatry. 2008;49(5):535\u201342. https:\/\/doi.org\/10.1111\/j.1469-7610.2007.01857.x.","journal-title":"J Child Psychol Psychiatry"},{"key":"395_CR266","doi-asserted-by":"publisher","DOI":"10.1037\/a0036088","author":"A Ronald","year":"2014","unstructured":"Ronald A, Larsson H, Anckars\u00e4ter H, Lichtenstein P. Symptoms of autism and ADHD: a Swedish twin study examining their overlap. J\u00a0Abnorm Psychol. 2014; https:\/\/doi.org\/10.1037\/a0036088.","journal-title":"J Abnorm Psychol"},{"issue":"4","key":"395_CR267","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/15748847113086660072","volume":"9","author":"DA Rossignol","year":"2014","unstructured":"Rossignol DA, Frye RE. Melatonin in autism spectrum disorders. CCP. 2014;9(4):326\u201334.","journal-title":"CCP"},{"key":"395_CR268","doi-asserted-by":"crossref","unstructured":"Saunders DC. Mindfulness-based ADHD treatment for children: a\u00a0pilot feasibility study. J\u00a0Acad Child Adoles Psych. 2019;58(Suppl\u00a010):312. American Academy of Child & Adolescent Psychiatry (AACAP) 66th Annual Meeting.","DOI":"10.1016\/j.jaac.2019.07.717"},{"issue":"5","key":"395_CR269","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/cap.2006.16.589","volume":"16","author":"L Scahill","year":"2006","unstructured":"Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, et al. A\u00a0prospective open trial of guanfacine in children with pervasive developmental disorders. J\u00a0Child Adolesc Psychopharmacol. 2006;16(5):589\u201398.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"12","key":"395_CR270","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1176\/appi.ajp.2015.15010055","volume":"172","author":"L Scahill","year":"2015","unstructured":"Scahill L, McCracken JT, King BH, Rockhill C, Shah B, Politte L, et al. Extended release guanfacine for hyperactivity in children with autism spectrum disorder. Am J Psychiatry. 2015;172(12):1197\u2013206. https:\/\/doi.org\/10.1176\/appi.ajp.2015.15010055.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"395_CR271","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1097\/01.chi.0000220854.79144.e7","volume":"45","author":"L Scahill","year":"2006","unstructured":"Scahill L, McDougle CJ, Williams SK, Dimitropoulos A, Aman MG, McCracken JT, et al. Children\u2019s yale-brown obsessive compulsive scale modified for pervasive developmental disorders. J\u00a0Am Acad Child Adoles Psych. 2006;45(9):1114\u201323. https:\/\/doi.org\/10.1097\/01.chi.0000220854.79144.e7.","journal-title":"J\u00a0Am Acad Child Adoles Psych."},{"issue":"3","key":"395_CR272","first-page":"45","volume":"43","author":"A Scheltema Beduin","year":"2010","unstructured":"Scheltema Beduin A, de Haan L. Off-label second generation antipsychotics for impulse regulation disorders: a\u00a0review. Psychopharmacol Bull. 2010;43(3):45\u201381.","journal-title":"Psychopharmacol Bull"},{"issue":"16","key":"395_CR273","first-page":"859","volume":"104","author":"K Schmeck","year":"2015","unstructured":"Schmeck K. Antipsychotika im Kindes- und Jugendalter: pro und contra [Pros and cons of antipsychotics in children and adolescents]. Prax Schweiz Rundsch Med. 2015;104(16):859\u201364.","journal-title":"Prax Schweiz Rundsch Med"},{"issue":"10","key":"395_CR274","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11920-014-0479-3","volume":"16","author":"BN Schneider","year":"2014","unstructured":"Schneider BN, Enenbach M. Managing the risks of ADHD treatments. Current Psych Rep. 2014;16(10):479. https:\/\/doi.org\/10.1007\/s11920-014-0479-3.","journal-title":"Current Psych Rep"},{"issue":"5","key":"395_CR275","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1023\/A:1005535120023","volume":"30","author":"L Schreibman","year":"2000","unstructured":"Schreibman L. Intensive behavioral\/psychoeducational treatments for autism: research needs and future direction. J\u00a0Autism Dev Disord. 2000;30(5):373\u20138.","journal-title":"J Autism Dev Disord"},{"issue":"2","key":"395_CR276","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/01.CHI.0000037017.34553.2E","volume":"43","author":"SB Schur","year":"2003","unstructured":"Schur SB, Sikich L, Findling RL, Malone RP, Crismon ML, Derivan A, et al. Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part ii. A review. J\u00a0Am Acad Child Adolesc Psychiatry. 2003;43(2):132\u201344. https:\/\/doi.org\/10.1097\/01.CHI.0000037017.34553.2E.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"360","key":"395_CR277","first-page":"1","volume":"9","author":"J Scott","year":"2018","unstructured":"Scott J, Etain B, Bellivier F. Can an integrated science approach to precision medicine research improve lithium treatment in bipolar disorders? Front Psychiatry. 2018;9(360):1\u201310.","journal-title":"Front Psychiatry"},{"issue":"5","key":"395_CR278","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2165\/00148581-200709050-00006","volume":"9","author":"LJ Scott","year":"2007","unstructured":"Scott LJ, Dhillon S. Risperidone: a\u00a0review of its use in the treatment of irritability associated with autistic disorder in children and adolescents. Paediatr Drugs. 2007;9(5):343\u201354.","journal-title":"Paediatr Drugs"},{"key":"395_CR279","doi-asserted-by":"crossref","unstructured":"Scotto Rosato N, Correll CU, Pappadopulos E, Chait A, Crystal S, Jensen PS on\u00a0behalf of the Treatment of Maladaptive Aggressive in Youth\u00a0Steering Committee. Treatment of maladaptive aggression in youth: CERT guidelines II. treatments and ongoing management. Pediatrics. 2012;129(6):e1577\u2013586. https:\/\/doi.org\/10.1542\/peds.2010-1361.","DOI":"10.1542\/peds.2010-1361"},{"issue":"7","key":"395_CR280","doi-asserted-by":"publisher","first-page":"779","DOI":"10.5664\/jcsm.3872","volume":"10","author":"GE Silva","year":"2014","unstructured":"Silva GE, Goodwin JL, Vana KD, Vasquez MM, Wilcox PG, Quan SF. Restless legs syndrome, sleep, and quality of life among adolescents and young adults. J\u00a0Clin Sleep Med. 2014;10(7):779\u201386. https:\/\/doi.org\/10.5664\/jcsm.3872.","journal-title":"J Clin Sleep Med"},{"issue":"8","key":"395_CR281","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/CHI.0b013e318179964f","volume":"47","author":"E Simonoff","year":"2008","unstructured":"Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a\u00a0population-derived sample. J\u00a0Am Acad Child Adolesc Psychiatry. 2008;47(8):921\u20139. https:\/\/doi.org\/10.1097\/CHI.0b013e318179964f.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"395_CR282","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1469-7610.2012.02569.x","volume":"54","author":"E Simonoff","year":"2013","unstructured":"Simonoff E, Taylor E, Baird G, Bernard S, Chadwick O, Liang H, et al. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability. J\u00a0Child Psychol Psychiatry. 2013;54(5):527\u201335. https:\/\/doi.org\/10.1111\/j.1469-7610.2012.02569.x.","journal-title":"J Child Psychol Psychiatry"},{"key":"395_CR283","unstructured":"sleepjunkie. The ultimate guide to helping children with autism sleep soundly at night. https:\/\/www.sleepjunkie.org\/autism-and-sleep\/, 2019. Accessed: 17 Jun 2021."},{"issue":"1","key":"395_CR284","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0166-4328(97)00175-7","volume":"98","author":"MV Solanto","year":"1998","unstructured":"Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a\u00a0review and integration. Behav Brain Res. 1998;98(1):127\u201352.","journal-title":"Behav Brain Res"},{"issue":"2","key":"395_CR285","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1542\/peds.2014-1581","volume":"136","author":"C Southammakosane","year":"2015","unstructured":"Southammakosane C, Schmitz\u00a0K. Pediatric psychopharmacology for treatment of ADHD, depression, and anxiety. Pediatrics. 2015;136(2):351\u20139. https:\/\/doi.org\/10.1542\/peds.2014-1581.","journal-title":"Pediatrics"},{"issue":"1","key":"395_CR286","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.rasd.2011.09.001","volume":"6","author":"M Sowa","year":"2012","unstructured":"Sowa M, Meulenbroek K. Effects of physical exercise on autism spectrum disorders: a\u00a0meta-analysis. Res Autrism Spectr Disord. 2012;6(1):46\u201357. https:\/\/doi.org\/10.1016\/j.rasd.2011.09.001.","journal-title":"Res Autrism Spectr Disord"},{"key":"395_CR287","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1203\/PDR.0b013e31819e7168","volume":"65","author":"SJ Spence","year":"2009","unstructured":"Spence SJ, Schneider MT. The role of epilepsy and epileptiform EEGs in autism spectrum disorders. Pediatr Res. 2009;65:599\u2013606.","journal-title":"Pediatr Res"},{"issue":"5","key":"395_CR288","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1542\/peds.2012-3774","volume":"132","author":"D Spencer","year":"2013","unstructured":"Spencer D, Marchall J, Post B, Kulakodlu M, Newschaffer C, Dennen T, et al. Psychotropic medication use and polypharmacy in children with autism spectrum disorders. Pediatrics. 2013;132(5):833\u201340.","journal-title":"Pediatrics"},{"key":"395_CR289","doi-asserted-by":"crossref","unstructured":"Srinivasan SM, Bhat AN. A\u00a0review of \u201cmusic and movement\u201d therapies for children with autism: embodied interventions for multisystem development. Front Integrat Neurosci. 2013;7(22):1\u201315. https:\/\/doi.org\/10.3389\/fnint.2013.00022.","DOI":"10.3389\/fnint.2013.00022"},{"issue":"4","key":"395_CR290","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1345\/aph.1H527","volume":"41","author":"JM Stachnik","year":"2007","unstructured":"Stachnik JM, Nunn-Thompson C. Use of atypical antipsychotics in the treatment of autistic disorder. Ann Pharmacother. 2007;41(4):626\u201334.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"395_CR291","first-page":"57","volume":"29","author":"C Stavrakaki","year":"2004","unstructured":"Stavrakaki C, Antochi R, Emery PC. Olanzapine in the treatment of pervasive developmental disorders: a\u00a0case series analysis. JPN. 2004;29(1):57\u201360.","journal-title":"JPN"},{"issue":"1","key":"395_CR292","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/cap.1997.7.9","volume":"7","author":"RJ Steingard","year":"1997","unstructured":"Steingard RJ, Zimnitzky B, DeMaso DR, Bauman ML, Bucci JP. Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. J\u00a0Child Adolesc Psychopharmacol. 1997;7(1):9\u201315.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"395_CR293","doi-asserted-by":"crossref","unstructured":"Stevenson J, Buitelaar J, Cortese S, Ferrin M, Konofal E, Lecendreux M, et al., and on behalf of the European ADHD Guidelines Group. Research review: The role of diet in the treatment of attention-deficit\/hyperactivity disorder \u2013 an appraisal of the evidence on efficacy and recommendations on the design of future studies. J\u00a0Child Psychol Psychiat. 2014;55(5):416\u201327. https:\/\/doi.org\/0.1111\/jcpp.12215.","DOI":"10.1111\/jcpp.12215"},{"issue":"1","key":"395_CR294","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.chc.2013.07.005","volume":"23","author":"KA Stigler","year":"2014","unstructured":"Stigler KA. Psychopharmacologic management of serious behavioral disturbance in ASD. Child Adolesc Psychiatr Clin N Am. 2014;23(1):73\u201382.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"4","key":"395_CR295","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.chc.2008.06.002","volume":"17","author":"KA Stigler","year":"2008","unstructured":"Stigler KA, McDougle CJ. Pharmacotherapy of irritability in pervasive developmental disorders. Child Adolesc Psychiatr Clin N Am. 2008;17(4):739\u201352.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"Cd011144","key":"395_CR296","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD011144.pub2","volume":"11","author":"N Sturman","year":"2017","unstructured":"Sturman N, Deckx L, van Driel ML. Methylphenidate for children and adolescents with autism spectrum disorder. Cochrane Database Sys Rev. 2017;11(Cd011144):1\u201398. https:\/\/doi.org\/10.1002\/14651858.CD011144.pub2.","journal-title":"Cochrane Database Sys Rev"},{"key":"395_CR297","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2147\/NDT.S39516","volume":"10","author":"M Sung","year":"2014","unstructured":"Sung M, Chin CH, Lim CG, Liew HSA, Lim CS, Kashala E, et al. What\u2019s in the pipeline? Drugs in development for autism spectrum disorder. NDT. 2014;10:371\u201381.","journal-title":"NDT"},{"key":"395_CR298","doi-asserted-by":"crossref","unstructured":"Tarrant N, Roy M, Deb S, Odedra S, Retzer A, Roy A. The effectiveness of methylphenidate in the management of attention deficit hyperactivity disorder (ADHD) in people with intellectual disabilities: A\u00a0systematic review. Res Development Disabil. 2018;83:217\u2013232. https:\/\/doi.org\/10.1016\/j.ridd.2018.08.017.","DOI":"10.1016\/j.ridd.2018.08.017"},{"issue":"2","key":"395_CR299","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/YCO.0000000000000043","volume":"27","author":"BJ Tonge","year":"2014","unstructured":"Tonge BJ, Bull K, Brereton A, Wilson R. A\u00a0review of evidence-based early intervention for behavioural problems in children with autism spectrum disorder: the core components of effective programs, child-focused interventions and comprehensive treatment models. Curr Opin Psychiatry. 2014;27(2):158\u201365.","journal-title":"Curr Opin Psychiatry"},{"key":"395_CR300","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.neubiorev.2018.05.004","volume":"90","author":"N Torres","year":"2018","unstructured":"Torres N, Martins D, Ant\u2019onio JS, Prata D, Ver\u00edssimo M. How do hypothalamic nonapeptides shape youth\u2019s sociality? a\u00a0systematic review on oxytocin, vasopressin and human socio-emotional development. Neurosci Biobehav Rev. 2018;90:309\u201331. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.05.004.","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"395_CR301","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/dneu.20778","volume":"70","author":"I Torres-Aleman","year":"2010","unstructured":"Torres-Aleman I. Toward a\u00a0comprehensive neurobiology of IGF\u2011I. Devel Neurobio. 2010;70(5):384\u201396. https:\/\/doi.org\/10.1002\/dneu.20778.","journal-title":"Devel Neurobio"},{"issue":"1","key":"395_CR302","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/0031512517743823","volume":"125","author":"CVA Toscano","year":"2018","unstructured":"Toscano CVA, Carvalho HM, Ferreira JP. Exercise effects for children with autism spectrum disorder: metabolic health, autistic traits, and quality of life. Percept Mot Skills. 2018;125(1):126\u201346. https:\/\/doi.org\/10.1177\/0031512517743823.","journal-title":"Percept Mot Skills"},{"key":"395_CR303","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.braindev.2010.05.007","volume":"32","author":"R Tuchman","year":"2010","unstructured":"Tuchman R, Alessandri M, Cuccaro M. Autism spectrum disorder and epilepsy: Moving towards a\u00a0comprehensive approach to treatment. Brain Dev. 2010;32:719\u201330.","journal-title":"Brain Dev"},{"key":"395_CR304","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00751","author":"C Tye","year":"2019","unstructured":"Tye C, Runicles AK, Whitehouse AJO, Alvares GA. Characterizing the interplay between autism spectrum disorder and comorbid medical conditions: an integrative review. Front Psychiatry. 2019; https:\/\/doi.org\/10.3389\/fpsyt.2018.00751.","journal-title":"Front Psychiatry"},{"issue":"8","key":"395_CR305","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00787-019-01275-y","volume":"28","author":"J Uren","year":"2019","unstructured":"Uren J, Richdale AL, Cotton SM, Whitehouse AJO. Sleep problems and anxiety from 2 to 8 years and the influence of autistic traits: a\u00a0longitudinal study. Eur Child. 2019;28(8):1117\u201327. https:\/\/doi.org\/10.1007\/s00787-019-01275-y.","journal-title":"Eur Child"},{"issue":"1","key":"395_CR306","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jne.12355","volume":"27","author":"MH van Ijzendoorn","year":"2015","unstructured":"van Ijzendoorn MH, Bakermans-Kranenburg MJ. The role of oxytocin in parenting and as augmentative pharmacotherapy; critical issues and bold conjectures. J\u00a0Neuroendocrinology. 2015;27(1):1\u20138. https:\/\/doi.org\/10.1111\/jne.12355.","journal-title":"J\u00a0Neuroendocrinology."},{"key":"395_CR307","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jad.2014.06.042","volume":"168","author":"G Vanucchi","year":"2014","unstructured":"Vanucchi G, Masi G, Toni C, Dell\u2019Osso L, Erfurth A, Perugi G. Bipolar disorder in adults with Asperger\u2019s Syndrome: a\u00a0systematic review. J\u00a0Affect Disord. 2014;168:151\u201360.","journal-title":"J Affect Disord"},{"issue":"2","key":"395_CR308","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40675-015-0012-1","volume":"1","author":"OJ Veatch","year":"2015","unstructured":"Veatch OJ, Maxwell-Horn AC, Malow BA. Sleep in autism spectrum disorders. Curr Sleep Medicine Rep. 2015;1(2):131\u201340.","journal-title":"Curr Sleep Medicine Rep"},{"issue":"14","key":"395_CR309","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1073\/pnas.1112345109","volume":"109","author":"J Veenstra-VanderWeele","year":"2012","unstructured":"Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, ShahCR, et al. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proceed Nat Acad Sci. 2012;109(14):5469\u201374. https:\/\/doi.org\/10.1073\/pnas.1112345109.","journal-title":"Sci"},{"key":"395_CR310","doi-asserted-by":"publisher","first-page":"e911","DOI":"10.1542\/peds.2008-0257","volume":"122","author":"S Venkateswaran","year":"2008","unstructured":"Venkateswaran S, Shevell M. The case against routine encephalography in specific language impairment. Pediatrics. 2008;122:e911\u2013e6.","journal-title":"Pediatrics"},{"issue":"3","key":"395_CR311","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2217\/bmm.14.12","volume":"8","author":"L Wang","year":"2014","unstructured":"Wang L, Conion MA, Christophersen CT, Sorich MJ, Angley MT. Gastrointestinal microbiota and metabolite biomarkers in children with autism spectrum disorders. Biomarkers Med. 2014;8(3):331\u201344.","journal-title":"Biomarkers Med"},{"issue":"12","key":"395_CR312","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1016\/j.ridd.2013.08.015","volume":"34","author":"F Ward","year":"2013","unstructured":"Ward F, Tharian P, Roy S, Deb M, Unwin GL. Efficacy of beta blockers in the management of problem behaviours in people with intellectual disabilities: a\u00a0systematic review. Res Dev Disabil. 2013;34(12):4293\u2013303.","journal-title":"Res Dev Disabil"},{"key":"395_CR313","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1093\/brain\/awv249","volume":"138","author":"T Watanabe","year":"2015","unstructured":"Watanabe T, Kuroda M, Kuwabara H, Aoki Y, Iwashiro N, Tatsunobu N, et al. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism. Brain. 2015;138:3400\u201312.","journal-title":"Brain"},{"issue":"2","key":"395_CR314","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1017\/S0012162205000186","volume":"47","author":"S Weiskop","year":"2005","unstructured":"Weiskop S, Richdale A, Matthews J. Behavioural treatment to reduce sleep problems in children with autism or fragile x syndrome. Dev Med Child Neurol. 2005;47(2):94\u2013104.","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"395_CR315","doi-asserted-by":"publisher","first-page":"e3815","DOI":"10.1371\/journal.pone.0003815","volume":"3","author":"JR Weissman","year":"2008","unstructured":"Weissman JR, Kelley RI, Bauman ML, Cohen BH, Murray KF, Mitchell RL, et al. Mitochondrial disease in autism spectrum disorder patients: a\u00a0cohort analysis. PLoS ONE. 2008;3(11):e3815.","journal-title":"PLoS ONE"},{"key":"395_CR316","doi-asserted-by":"crossref","unstructured":"Whitehouse AJ. Complementary and alternative medicine for autism spectrum disorders: Rationale, safety and efficacy. J\u00a0Paediatrics Child Health. 2013. https:\/\/doi.org\/10.1111\/jpc.12242.","DOI":"10.1111\/jpc.12242"},{"key":"395_CR317","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1017\/S0012162204000611","volume":"46","author":"L Wiggs","year":"2004","unstructured":"Wiggs L, Stores G. Sleep patterns and sleep disorders in children with autistic spectrum disorders: insights using parent report and actigraphy. Dev Med Child Neurol. 2004;46:372\u201380.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"395_CR318","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2989\/17280583.2019.1608830","volume":"31","author":"LAMW Wijnhoven","year":"2019","unstructured":"Wijnhoven LAMW, Niels-Kessels H, Creemers DHM, Vermulst AA, Otten R, Engels RCME. Prevalence of comorbid depressive symptoms and suicidal ideation in children with autism spectrum disorder and elevated anxiety symptoms. J\u00a0Child Adolesc Ment Health. 2019;31(1):77\u201384. https:\/\/doi.org\/10.2989\/17280583.2019.1608830.","journal-title":"J Child Adolesc Ment Health"},{"key":"395_CR319","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004677.pub3","author":"K Williams","year":"2013","unstructured":"Williams K, Brignell A, Randall M, Silove P, Hazell N. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2013; https:\/\/doi.org\/10.1002\/14651858.CD004677.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"395_CR320","unstructured":"World Health Organization. ICD-11 for mortality and morbidity statistics (Version : 04\/2019). https:\/\/icd.who.int\/browse11\/l-m\/en, 2019. Accessed: 17 Jun 2021"},{"key":"395_CR321","doi-asserted-by":"crossref","unstructured":"Yamasue H, Domes G. Behav Pharmacol Neuropep: Oxytocin, volume\u00a035 of Current Topics in Behavioral Neurosciences, chapter Oxytocin and Autism Spectrum Disorders, pages 449\u2013465. Springer, 2019. https:\/\/doi.org\/10.1007\/7854_2017_24.","DOI":"10.1007\/7854_2017_24"},{"issue":"9","key":"395_CR322","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/mp.2015.162","volume":"21","author":"CJ Yatawara","year":"2016","unstructured":"Yatawara CJ, Einfeld SL, Hickie IB, Davenport TA, Guastella AJ. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a\u00a0randomized clinical crossover trial. Mol Psychiatry. 2016;21(9):1225\u201331. https:\/\/doi.org\/10.1038\/mp.2015.162.","journal-title":"Mol Psychiatry"},{"key":"395_CR323","doi-asserted-by":"crossref","unstructured":"Zaboski BA, Storch EA. Comorbid autism spectrum disorder and anxiety disorders: a\u00a0brief review. Future Neurol. 2018;13(1):31\u20137. https:\/\/doi.org\/10.2217\/fnl-2017-0030.","DOI":"10.2217\/fnl-2017-0030"},{"issue":"4","key":"395_CR324","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1027\/0227-5910\/a000458","volume":"38","author":"S Zahid","year":"2017","unstructured":"Zahid S, Upthegrove R. Suicidality in autistic spectrum disorders. Crisis. 2017;38(4):237\u201346. https:\/\/doi.org\/10.1027\/0227-5910\/a000458.","journal-title":"Crisis"},{"issue":"6","key":"395_CR325","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1542\/peds.2012-0876","volume":"129","author":"M Zimmer","year":"2012","unstructured":"Zimmer M, Desch L. Sensory integration therapies for children with developmental and behavioral disorders. Pediatrics. 2012;129(6):1186\u20139. https:\/\/doi.org\/10.1542\/peds.2012-0876.","journal-title":"Pediatrics"},{"issue":"8","key":"395_CR326","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.euroneuro.2011.04.001","volume":"21","author":"A Zuddas","year":"2011","unstructured":"Zuddas A, Zanni R, Usala T. Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a\u00a0review of the randomized controlled studies. Eur Neuropsychopharmacol. 2011;21(8):600\u201320.","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["neuropsychiatrie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40211-021-00395-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40211-021-00395-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40211-021-00395-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T09:33:39Z","timestamp":1631180019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40211-021-00395-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":326,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["395"],"URL":"https:\/\/doi.org\/10.1007\/s40211-021-00395-9","relation":{},"ISSN":["0948-6259","2194-1327"],"issn-type":[{"value":"0948-6259","type":"print"},{"value":"2194-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"assertion":[{"value":"12 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors state that no author has a\u00a0conflict of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}